G0008 Admin influenza virus vac Administration of influenza virus vaccine 
G0009 Admin pneumococcal vaccine Administration of pneumococcal vaccine 
G0010 Admin hepatitis b vaccine Administration of hepatitis b vaccine 
G0027 Semen analysis Semen analysis; presence and/or motility of sperm excluding huhner 
G0068 Adm of infusion drug in home Professional services for the administration of anti-infective pain management chelation pulmonary hypertension and/or inotropic infusion drug(s) for each infusion drug administration calendar day in the individual's home each 15 minutes 
G0069 Adm of immune drug in home Professional services for the administration of subcutaneous immunotherapy for each infusion drug administration calendar day in the individual's home each 15 minutes 
G0070 Adm of chemo drug in home Professional services for the administration of chemotherapy for each infusion drug administration calendar day in the individual's home each 15 minutes 
G0071 Comm svcs by rhc/fqhc 5 min Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner occurring in lieu of an office visit; rhc or fqhc only 
G0076 Care manag h vst new pt 20 m Brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0077 Care manag h vst new pt 30 m Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0078 Care manag h vst new pt 45 m Moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0079 Care manag h vst new pt 60 m Comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0080 Care manag h vst new pt 75 m Extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0081 Care man h v ext pt 20 mi Brief (20 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0082 Care man h v ext pt 30 m Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0083 Care man h v ext pt 45 m Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0084 Care man h v ext pt 60 m Comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0085 Care man h v ext pt 75 m Extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0086 Care man home care plan 30 m Limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0087 Care man home care plan 60 m Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility) 
G0101 Ca screen;pelvic/breast exam Cervical or vaginal cancer screening; pelvic and clinical breast examination 
G0102 Prostate ca screening; dre Prostate cancer screening; digital rectal examination 
G0103 Psa screening Prostate cancer screening; prostate specific antigen test (psa) 
G0104 Ca screen;flexi sigmoidscope Colorectal cancer screening; flexible sigmoidoscopy 
G0105 Colorectal scrn; hi risk ind Colorectal cancer screening; colonoscopy on individual at high risk 
G0106 Colon ca screen;barium enema Colorectal cancer screening; alternative to g0104 screening sigmoidoscopy barium enema 
G0108 Diab manage trn  per indiv Diabetes outpatient self-management training services individual per 30 minutes 
G0109 Diab manage trn ind/group Diabetes outpatient self-management training services group session (2 or more) per 30 minutes 
G0117 Glaucoma scrn hgh risk direc Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist 
G0118 Glaucoma scrn hgh risk direc Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist 
G0120 Colon ca scrn; barium enema Colorectal cancer screening; alternative to g0105 screening colonoscopy barium enema. 
G0121 Colon ca scrn not hi rsk ind Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 
G0122 Colon ca scrn; barium enema Colorectal cancer screening; barium enema 
G0123 Screen cerv/vag thin layer Screening cytopathology cervical or vaginal (any reporting system) collected in preservative fluid automated thin layer preparation screening by cytotechnologist under physician supervision 
G0124 Screen c/v thin layer by md Screening cytopathology cervical or vaginal (any reporting system) collected in preservative fluid automated thin layer preparation requiring interpretation by physician 
G0127 Trim nail(s) Trimming of dystrophic nails any number 
G0128 Corf skilled nursing service Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility each 10 minutes beyond the first 5 minutes 
G0129 Partial hosp prog service Occupational therapy services requiring the skills of a qualified occupational therapist furnished as a component of a partial hospitalization treatment program per session (45 minutes or more) 
G0130 Single energy x-ray study Single energy x-ray absorptiometry (sexa) bone density study one or more sites; appendicular skeleton (peripheral) (e.g. radius wrist heel) 
G0141 Scr c/v cytoautosys and md Screening cytopathology smears cervical or vaginal performed by automated system with manual rescreening requiring interpretation by physician 
G0143 Scr c/v cytothinlayerrescr Screening cytopathology cervical or vaginal (any reporting system) collected in preservative fluid automated thin layer preparation with manual screening and rescreening by cytotechnologist under physician supervision 
G0144 Scr c/v cytothinlayerrescr Screening cytopathology cervical or vaginal (any reporting system) collected in preservative fluid automated thin layer preparation with screening by automated system under physician supervision 
G0145 Scr c/v cytothinlayerrescr Screening cytopathology cervical or vaginal (any reporting system) collected in preservative fluid automated thin layer preparation with screening by automated system and manual rescreening under physician supervision 
G0147 Scr c/v cyto automated sys Screening cytopathology smears cervical or vaginal performed by automated system under physician supervision 
G0148 Scr c/v cyto autosys rescr Screening cytopathology smears cervical or vaginal performed by automated system with manual rescreening 
G0151 Hhcp-serv of ptea 15 min Services performed by a qualified physical therapist in the home health or hospice setting each 15 minutes 
G0152 Hhcp-serv of otea 15 min Services performed by a qualified occupational therapist in the home health or hospice setting each 15 minutes 
G0153 Hhcp-svs of s/l pathea 15mn Services performed by a qualified speech-language pathologist in the home health or hospice setting each 15 minutes 
G0154 Hhcp-svs of rnea 15 min Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting each 15 minutes 
G0155 Hhcp-svs of cswea 15 min Services of clinical social worker in home health or hospice settings each 15 minutes 
G0156 Hhcp-svs of aideea 15 min Services of home health/hospice aide in home health or hospice settings each 15 minutes 
G0157 Hhc pt assistant ea 15 Services performed by a qualified physical therapist assistant in the home health or hospice setting each 15 minutes 
G0158 Hhc ot assistant ea 15 Services performed by a qualified occupational therapist assistant in the home health or hospice setting each 15 minutes 
G0159 Hhc pt maint ea 15 min Services performed by a qualified physical therapist in the home health setting in the establishment or delivery of a safe and effective physical therapy maintenance program each 15 minutes 
G0160 Hhc occup therapy ea 15 Services performed by a qualified occupational therapist in the home health setting in the establishment or delivery of a safe and effective occupational therapy maintenance program each 15 minutes 
G0161 Hhc slp ea 15 min Services performed by a qualified speech-language pathologist in the home health setting in the establishment or delivery of a safe and effective speech-language pathology maintenance program each 15 minutes 
G0162 Hhc rn e&m plan svs 15 min Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting) 
G0163 Hhc lpn/rn obs/asses ea 15 Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting) 
G0164 Hhc lis nurse train ea 15 Skilled services of a licensed nurse (lpn or rn) in the training and/or education of a patient or family member in the home health or hospice setting each 15 minutes 
G0166 Extrnl counterpulse per tx External counterpulsation per treatment session 
G0168 Wound closure by adhesive Wound closure utilizing tissue adhesive(s) only 
G0173 Linear acc stereo radsur com Linear accelerator based stereotactic radiosurgery complete course of therapy in one session 
G0175 Opps servicesched team conf Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present 
G0176 Opps/php;activity therapy Activity therapy such as music dance art or play therapies not for recreation related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 
G0177 Opps/php; train & educ serv Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 
G0179 Md recertification hha pt Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present) including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs per re-certification period 
G0180 Md certification hha patient Physician certification for medicare-covered home health services under a home health plan of care (patient not present) including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs per certification period 
G0181 Home health care supervision Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans review of subsequent reports of patient status review of laboratory and other studies communication (including telephone calls) with other health care professionals involved in the patient's care integration of new information into the medical treatment plan and/or adjustment of medical therapy within a calendar month 30 minutes or more 
G0182 Hospice care supervision Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans review of subsequent reports of patient status review of laboratory and other studies communication (including telephone calls) with other health care professionals involved in the patient's care integration of new information into the medical treatment plan and/or adjustment of medical therapy within a calendar month 30 minutes or more 
G0186 Dstry eye lesnfdr vssl tech Destruction of localized lesion of choroid (for example choroidal neovascularization); photocoagulation feeder vessel technique (one or more sessions) 
G0202 Scr mammo bi incl cad Screening mammography bilateral (2-view study of each breast) including computer-aided detection (cad) when performed 
G0204 Dx mammo incl cad bi Diagnostic mammography including computer-aided detection (cad) when performed; bilateral 
G0206 Dx mammo incl cad uni Diagnostic mammography including computer-aided detection (cad) when performed; unilateral 
G0219 Pet img wholbod melano nonco Pet imaging whole body; melanoma for non-covered indications 
G0235 Pet not otherwise specified Pet imaging any site not otherwise specified 
G0237 Therapeutic procd strg endur Therapeutic procedures to increase strength or endurance of respiratory muscles face to face one on one each 15 minutes (includes monitoring) 
G0238 Oth resp proc indiv Therapeutic procedures to improve respiratory function other than described by g0237 one on one face to face per 15 minutes (includes monitoring) 
G0239 Oth resp proc group Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles two or more individuals (includes monitoring) 
G0245 Initial foot exam pt lops Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops (2) a patient history (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot hindfoot and toe web spaces (b) evaluation of a protective sensation (c) evaluation of foot structure and biomechanics (d) evaluation of vascular status and skin integrity and (e) evaluation and recommendation of footwear and (4) patient education 
G0246 Followup eval of foot pt lop Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history (2) a physical examination that includes: (a) visual inspection of the forefoot hindfoot and toe web spaces (b) evaluation of protective sensation (c) evaluation of foot structure and biomechanics (d) evaluation of vascular status and skin integrity and (e) evaluation and recommendation of footwear and (3) patient education 
G0247 Routine footcare pt w lops Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds (2) debridement of corns and calluses and (3) trimming and debridement of nails 
G0248 Demonstrate use home inr mon Demonstration prior to initiation of home inr monitoring for patient with either mechanical heart valve(s) chronic atrial fibrillation or venous thromboembolism who meets medicare coverage criteria under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor obtaining at least one blood sample provision of instructions for reporting home inr test results and documentation of patient's ability to perform testing and report results 
G0249 Provide inr test mater/equip Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s) chronic atrial fibrillation or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials billing units of service include 4 tests 
G0250 Md inr test revie inter mgmt Physician review interpretation and patient management of home inr testing for patient with either mechanical heart valve(s) chronic atrial fibrillation or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests 
G0251 Linear acc based stero radio Linear accelerator based stereotactic radiosurgery delivery including collimator changes and custom plugging fractionated treatment all lesions per session maximum five sessions per course of treatment 
G0252 Pet imaging initial dx Pet imaging full and partial-ring pet scanners only for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g. initial staging of axillary lymph nodes) 
G0255 Current percep threshold tst Current perception threshold/sensory nerve conduction test (snct) per limb any nerve 
G0257 Unsched dialysis esrd pt hos Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility 
G0259 Inject for sacroiliac joint Injection procedure for sacroiliac joint; arthrography 
G0260 Inj for sacroiliac jt anesth Injection procedure for sacroiliac joint; provision of anesthetic steroid and/or other therapeutic agent with or without arthrography 
G0268 Removal of impacted wax md Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing 
G0269 Occlusive device in vein art Placement of occlusive device into either a venous or arterial access site post surgical or interventional procedure (e.g. angioseal plug vascular plug) 
G0270 Mnt subs tx for change dx Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis medical condition or treatment regimen (including additional hours needed for renal disease) individual face to face with the patient each 15 minutes 
G0271 Group mnt 2 or more 30 mins Medical nutrition therapy reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis medical condition or treatment regimen (including additional hours needed for renal disease) group (2 or more individuals) each 30 minutes 
G0276 Pild/placebo control clin tr Blinded procedure for lumbar stenosis percutaneous image-guided lumbar decompression (pild) or placebo-control performed in an approved coverage with evidence development (ced) clinical trial 
G0277 Hbot full body chamber 30m Hyperbaric oxygen under pressure full body chamber per 30 minute interval 
G0278 Iliac art angiocardiac cath Iliac and/or femoral artery angiography non-selective bilateral or ipsilateral to catheter insertion performed at the same time as cardiac catheterization and/or coronary angiography includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery injection of dye production of permanent images and radiologic supervision and interpretation (list separately in addition to primary procedure) 
G0279 Tomosynthesis mammo Diagnostic digital breast tomosynthesis unilateral or bilateral (list separately in addition to 77065 or 77066) 
G0281 Elec stim unattend for press Electrical stimulation (unattended) to one or more areas for chronic stage iii and stage iv pressure ulcers arterial ulcers diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care 
G0282 Elect stim wound care not pd Electrical stimulation (unattended) to one or more areas for wound care other than described in g0281 
G0283 Elec stim other than wound Electrical stimulation (unattended) to one or more areas for indication(s) other than wound care as part of a therapy plan of care 
G0288 Recon cta for surg plan Reconstruction computed tomographic angiography of aorta for surgical planning for vascular surgery 
G0289 Arthro loose body + chondro Arthroscopy knee surgical for removal of loose body foreign body debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee 
G0293 Non-cov surg procclin trial Noncovered surgical procedure(s) using conscious sedation regional general or spinal anesthesia in a medicare qualifying clinical trial per day 
G0294 Non-cov proc clinical trial Noncovered procedure(s) using either no anesthesia or local anesthesia only in a medicare qualifying clinical trial per day 
G0295 Electromagnetic therapy onc Electromagnetic therapy to one or more areas for wound care other than described in g0329 or for other uses 
G0296 Visit to determ ldct elig Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) 
G0297 Ldct for lung ca screen Low dose ct scan (ldct) for lung cancer screening 
G0299 Hhs/hospice of rn ea 15 min Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting each 15 minutes 
G0300 Hhs/hospice of lpn ea 15 min Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting each 15 minutes 
G0302 Pre-op service lvrs complete Pre-operative pulmonary surgery services for preparation for lvrs complete course of services to include a minimum of 16 days of services 
G0303 Pre-op service lvrs 10-15dos Pre-operative pulmonary surgery services for preparation for lvrs 10 to 15 days of services 
G0304 Pre-op service lvrs 1-9 dos Pre-operative pulmonary surgery services for preparation for lvrs 1 to 9 days of services 
G0305 Post op service lvrs min 6 Post-discharge pulmonary surgery services after lvrs minimum of 6 days of services 
G0306 Cbc/diffwbc w/o platelet Complete cbc automated (hgb hct rbc wbc without platelet count) and automated wbc differential count 
G0307 Cbc without platelet Complete (cbc) automated (hgb hct rbc wbc; without platelet count) 
G0328 Fecal blood scrn immunoassay Colorectal cancer screening; fecal occult blood test immunoassay 1-3 simultaneous 
G0329 Electromagntic tx for ulcers Electromagnetic therapy to one or more areas for chronic stage iii and stage iv pressure ulcers arterial ulcers diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care 
G0333 Dispense fee initial 30 day Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary 
G0337 Hospice evaluation preelecti Hospice evaluation and counseling services pre-election 
G0339 Robot lin-radsurg com first Image-guided robotic linear accelerator-based stereotactic radiosurgery complete course of therapy in one session or first session of fractionated treatment 
G0340 Robt lin-radsurg fractx 2-5 Image-guided robotic linear accelerator-based stereotactic radiosurgery delivery including collimator changes and custom plugging fractionated treatment all lesions per session second through fifth sessions maximum five sessions per course of treatment 
G0341 Percutaneous islet celltrans Percutaneous islet cell transplant includes portal vein catheterization and infusion 
G0342 Laparoscopy islet cell trans Laparoscopy for islet cell transplant includes portal vein catheterization and infusion 
G0343 Laparotomy islet cell transp Laparotomy for islet cell transplant includes portal vein catheterization and infusion 
G0364 Bone marrow aspirate &biopsy Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service 
G0365 Vessel mapping hemo access Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit including arterial inflow and venous outflow) 
G0372 Md service required for pmd Physician service required to establish and document the need for a power mobility device 
G0378 Hospital observation per hr Hospital observation service per hour 
G0379 Direct refer hospital observ Direct admission of patient for hospital observation care 
G0380 Lev 1 hosp type b ed visit Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name posted signs advertising or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made based on a representative sample of patient visits that occurred during that calendar year it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 
G0381 Lev 2 hosp type b ed visit Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name posted signs advertising or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made based on a representative sample of patient visits that occurred during that calendar year it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 
G0382 Lev 3 hosp type b ed visit Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name posted signs advertising or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made based on a representative sample of patient visits that occurred during that calendar year it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 
G0383 Lev 4 hosp type b ed visit Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name posted signs advertising or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made based on a representative sample of patient visits that occurred during that calendar year it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 
G0384 Lev 5 hosp type b ed visit Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name posted signs advertising or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made based on a representative sample of patient visits that occurred during that calendar year it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 
G0389 Ultrasound exam aaa screen Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening 
G0390 Trauma respons w/hosp criti Trauma response team associated with hospital critical care service 
G0396 Alcohol/subs interv 15-30mn Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g. audit dast) and brief intervention 15 to 30 minutes 
G0397 Alcohol/subs interv >30 min Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g. audit dast) and intervention greater than 30 minutes 
G0398 Home sleep test/type 2 porta Home sleep study test (hst) with type ii portable monitor unattended; minimum of 7 channels: eeg eog emg ecg/heart rate airflow respiratory effort and oxygen saturation 
G0399 Home sleep test/type 3 porta Home sleep test (hst) with type iii portable monitor unattended; minimum of 4 channels: 2 respiratory movement/airflow 1 ecg/heart rate and 1 oxygen saturation 
G0400 Home sleep test/type 4 porta Home sleep test (hst) with type iv portable monitor unattended; minimum of 3 channels 
G0402 Initial preventive exam Initial preventive physical examination; face-to-face visit services limited to new beneficiary during the first 12 months of medicare enrollment 
G0403 Ekg for initial prevent exam Electrocardiogram routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report 
G0404 Ekg tracing for initial prev Electrocardiogram routine ecg with 12 leads; tracing only without interpretation and report performed as a screening for the initial preventive physical examination 
G0405 Ekg interpret & report preve Electrocardiogram routine ecg with 12 leads; interpretation and report only performed as a screening for the initial preventive physical examination 
G0406 Inpt/tele follow up 15 Follow-up inpatient consultation limited physicians typically spend 15 minutes communicating with the patient via telehealth 
G0407 Inpt/tele follow up 25 Follow-up inpatient consultation intermediate physicians typically spend 25 minutes communicating with the patient via telehealth 
G0408 Inpt/tele follow up 35 Follow-up inpatient consultation complex physicians typically spend 35 minutes communicating with the patient via telehealth 
G0409 Corf related serv 15 mins ea Social work and psychological services directly relating to and/or furthering the patient's rehabilitation goals each 15 minutes face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf) 
G0410 Grp psych partial hosp 45-50 Group psychotherapy other than of a multiple-family group in a partial hospitalization setting approximately 45 to 50 minutes 
G0411 Inter active grp psych parti Interactive group psychotherapy in a partial hospitalization setting approximately 45 to 50 minutes 
G0412 Open tx iliac spine uni/bil Open treatment of iliac spine(s) tuberosity avulsion or iliac wing fracture(s) unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation when performed 
G0413 Pelvic ring fracture uni/bil Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring unilateral or bilateral (includes ilium sacroiliac joint and/or sacrum) 
G0414 Pelvic ring fx treat int fix Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring unilateral or bilateral includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami) 
G0415 Open tx post pelvic fxcture Open treatment of posterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring unilateral or bilateral includes internal fixation when performed (includes ilium sacroiliac joint and/or sacrum) 
G0416 Prostate biopsy any mthd Surgical pathology gross and microscopic examinations for prostate needle biopsy any method 
G0417 Sat biopsy prostate 21-40 Surgical pathology gross and microscopic examination for prostate needle  biopsy any method 21-40 specimens 
G0418 Sat biopsy prostate 41-60 Surgical pathology gross and microscopic examination for prostate needle  biopsy any method 41-60 specimens 
G0419 Sat biopsy prostate: >60 Surgical pathology gross and microscopic examination for prostate needle  biopsy any method >60 specimens 
G0420 Ed svc ckd ind per session Face-to-face educational services related to the care of chronic kidney disease; individual per session per one hour 
G0421 Ed svc ckd grp per session Face-to-face educational services related to the care of chronic kidney disease; group per session per one hour 
G0422 Intens cardiac rehab w/exerc Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise per session 
G0423 Intens cardiac rehab no exer Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise per session 
G0424 Pulmonary rehab w exer Pulmonary rehabilitation including exercise (includes monitoring) one hour per session up to two sessions per day 
G0425 Inpt/ed teleconsult30 Telehealth consultation emergency department or initial inpatient typically 30 minutes communicating with the patient via telehealth 
G0426 Inpt/ed teleconsult50 Telehealth consultation emergency department or initial inpatient typically 50 minutes communicating with the patient via telehealth 
G0427 Inpt/ed teleconsult70 Telehealth consultation emergency department or initial inpatient typically 70 minutes or more communicating with the patient via telehealth 
G0428 Collagen meniscus implant Collagen meniscus implant procedure for filling meniscal defects (e.g. cmi collagen scaffold menaflex) 
G0429 Dermal filler injection(s) Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g. as a result of highly active antiretroviral therapy) 
G0431 Drug screen multiple class Drug screen qualitative; multiple drug classes by high complexity test method (e.g. immunoassay enzyme assay) per patient encounter 
G0432 Eia hiv-1/hiv-2 screen Infectious agent antibody detection by enzyme immunoassay (eia) technique hiv-1 and/or hiv-2 screening 
G0433 Elisa hiv-1/hiv-2 screen Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique hiv-1 and/or hiv-2 screening 
G0434 Drug screen multi drug class Drug screen other than chromatographic; any number of drug classes by clia waived test or moderate complexity test per patient encounter 
G0435 Oral hiv-1/hiv-2 screen Infectious agent antibody detection by rapid antibody test hiv-1 and/or hiv-2 screening 
G0436 Tobacco-use counsel 3-10 min Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate greater than 3 minutes up to 10 minutes 
G0437 Tobacco-use counsel>10min Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive greater than 10 minutes 
G0438 Ppps initial visit Annual wellness visit; includes a personalized prevention plan of service (pps) initial visit 
G0439 Ppps subseq visit Annual wellness visit includes a personalized prevention plan of service (pps) subsequent visit 
G0442 Annual alcohol screen 15 min Annual alcohol misuse screening 15 minutes 
G0443 Brief alcohol misuse counsel Brief face-to-face behavioral counseling for alcohol misuse 15 minutes 
G0444 Depression screen annual Annual depression screening 15 minutes 
G0445 High inten beh couns std 30m High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face individual includes: education skills training and guidance on how to change sexual behavior; performed semi-annually 30 minutes 
G0446 Intens behave ther cardio dx Annual face-to-face intensive behavioral therapy for cardiovascular disease individual 15 minutes 
G0447 Behavior counsel obesity 15m Face-to-face behavioral counseling for obesity 15 minutes 
G0448 Place perm pacing cardiovert Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s) single or dual chamber with insertion of pacing electrode cardiac venous system for left ventricular pacing 
G0451 Devlopment test interpt&rep Development testing with interpretation and report per standardized instrument form 
G0452 Molecular pathology interpr Molecular pathology procedure; physician interpretation and report 
G0453 Cont intraop neuro monitor Continuous intraoperative neurophysiology monitoring from outside the operating room (remote or nearby) per patient (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) 
G0454 Md document visit by npp Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner physician assistant or clinical nurse specialist 
G0455 Fecal microbiota prep instil Preparation with instillation of fecal microbiota by any method including assessment of donor specimen 
G0456 Neg pre wound <=50 sq cm Negative pressure wound therapy (e.g. vacuum assisted drainage collection) using a mechanically-powered device not durable medical equipment including provision of cartridge and dressing(s) topical application(s) wound assessment and instructions for ongoing care per session; total wounds(s) surface area less than or equal to 50 square centimeters 
G0457 Neg pres wound >50 sq cm Negative pressure wound therapy (e.g. vacuum assisted drainage collection) using a mechanically-powered device not durable medical equipment including provision of cartridge and dressing(s) topical application(s) wound assessment and instructions for ongoing care per session; total wounds(s) surface area greater than 50 square centimeters 
G0458 Ldr prostate brachy comp rat Low dose rate (ldr) prostate brachytherapy services composite rate 
G0459 Telehealth inpt pharm mgmt Inpatient telehealth pharmacologic management including prescription use and review of medication with no more than minimal medical psychotherapy 
G0460 Autologous prp for ulcers Autologous platelet rich plasma for chronic wounds/ulcers including phlebotomy centrifugation and all other preparatory procedures administration and dressings per treatment 
G0461 Immunohisto/cyto chem 1st st Immunohistochemistry or immunocytochemistry per specimen; first single or multiplex antibody stain 
G0462 Immunohisto/cyto chem add Immunohistochemistry or immunocytochemistry per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) 
G0463 Hospital outpt clinic visit Hospital outpatient clinic visit for assessment and management of a patient 
G0464 Colorec ca scr sto bas dna Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g. kras ndrg4 and bmp3) 
G0466 Fqhc visit new patient Federally qualified health center (fqhc) visit new patient; a medically-necessary face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 
G0467 Fqhc visit estab pt Federally qualified health center (fqhc) visit established patient; a medically-necessary face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 
G0468 Fqhc visit ippe or awv Federally qualified health center (fqhc) visit ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv 
G0469 Fqhc visit mh new pt Federally qualified health center (fqhc) visit mental health new patient; a medically-necessary face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit 
G0470 Fqhc visit mh estab pt Federally qualified health center (fqhc) visit mental health established patient; a medically-necessary face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit 
G0471 Ven blood coll snf/hha Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 
G0472 Hep c screen high risk/other Hepatitis c antibody screening for individual at high risk and other covered indication(s) 
G0473 Group behave couns 2-10 Face-to-face behavioral counseling for obesity group (2-10) 30 minutes 
G0475 Hiv combination assay Hiv antigen/antibody combination assay screening 
G0476 Hpv combo assay ca screen Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv) high-risk types (e.g. 16 18 31 33 35 39 45 51 52 56 58 59 68) for cervical cancer screening must be performed in addition to pap test 
G0477 Drug test presump optical Drug test(s) presumptive any number of drug classes; any number of devices or procedures (e.g. immunoassay) capable of being read by direct optical observation only (e.g. dipsticks cups cards cartridges) includes sample validation when performed per date of service 
G0478 Drug test presump opt inst Drug test(s) presumptive any number of drug classes; any number of devices or procedures (e.g. immunoassay) read by instrument-assisted direct optical observation (e.g. dipsticks cups cards cartridges) includes sample validation when performed per date of service 
G0479 Drug test presump not opt Drug test(s) presumptive any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay enzyme assay tof maldi ldtd desi dart ghpc gc mass spectrometry) includes sample validation when performed per date of service 
G0480 Drug test def 1-7 classes Drug test(s) definitive utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers) including but not limited to gc/ms (any type single or tandem) and lc/ms (any type single or tandem and excluding immunoassays (e.g. ia eia elisa emit fpia) and enzymatic methods (e.g. alcohol dehydrogenase)) (2) stable isotope or other universally recognized internal standards in all samples (e.g. to control for matrix effects interferences and variations in signal strength) and (3) method or drug-specific calibration and matrix-matched quality control material (e.g. to control for instrument variations and mass spectral drift); qualitative or quantitative all sources includes specimen validity testing per day; 1-7 drug class(es) including metabolite(s) if performed 
G0481 Drug test def 8-14 classes Drug test(s) definitive utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers) including but not limited to gc/ms (any type single or tandem) and lc/ms (any type single or tandem and excluding immunoassays (e.g. ia eia elisa emit fpia) and enzymatic methods (e.g. alcohol dehydrogenase)) (2) stable isotope or other universally recognized internal standards in all samples (e.g. to control for matrix effects interferences and variations in signal strength) and (3) method or drug-specific calibration and matrix-matched quality control material (e.g. to control for instrument variations and mass spectral drift); qualitative or quantitative all sources includes specimen validity testing per day; 8-14 drug class(es) including metabolite(s) if performed 
G0482 Drug test def 15-21 classes Drug test(s) definitive utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers) including but not limited to gc/ms (any type single or tandem) and lc/ms (any type single or tandem and excluding immunoassays (e.g. ia eia elisa emit fpia) and enzymatic methods (e.g. alcohol dehydrogenase)) (2) stable isotope or other universally recognized internal standards in all samples (e.g. to control for matrix effects interferences and variations in signal strength) and (3) method or drug-specific calibration and matrix-matched quality control material (e.g. to control for instrument variations and mass spectral drift); qualitative or quantitative all sources includes specimen validity testing per day; 15-21 drug class(es) including metabolite(s) if performed 
G0483 Drug test def 22+ classes Drug test(s) definitive utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers) including but not limited to gc/ms (any type single or tandem) and lc/ms (any type single or tandem and excluding immunoassays (e.g. ia eia elisa emit fpia) and enzymatic methods (e.g. alcohol dehydrogenase)) (2) stable isotope or other universally recognized internal standards in all samples (e.g. to control for matrix effects interferences and variations in signal strength) and (3) method or drug-specific calibration and matrix-matched quality control material (e.g. to control for instrument variations and mass spectral drift); qualitative or quantitative all sources includes specimen validity testing per day; 22 or more drug class(es) including metabolite(s) if performed 
G0490 Home visit rn lpn by rhc/fq Face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies;  (services limited to rn or lpn only) 
G0491 Dialysis acu kidney no esrd Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd 
G0492 Md/oth eval acut kid no esrd Dialysis procedure with single evaluation by a physician or other qualified health care professional  for acute kidney injury without esrd 
G0493 Rn care ea 15 min hh/hospice Skilled services of a registered nurse (rn) for the observation and assessment of the patient's condition each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting) 
G0494 Lpn care ea 15min hh/hospice Skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient's condition each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting) 
G0495 Rn care train/edu in hh Skilled services of a registered nurse (rn) in the training and/or education of a patient or family member in the home health or hospice setting each 15 minutes 
G0496 Lpn care train/edu in hh Skilled services of a licensed practical nurse (lpn) in the training and/or education of a patient or family member in the home health or hospice setting each 15 minutes 
G0498 Chemo extend iv infus w/pump Chemotherapy administration intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies with continuation of the infusion in the community setting (e.g. home domiciliary rest home or assisted living) using a portable pump provided by the office/clinic includes follow up office/clinic visit at the conclusion of the infusion 
G0499 Hepb screen high risk indiv Hepatitis b screening in non-pregnant high risk individual includes hepatitis b surface antigen (hbsag) antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc) and is followed by a neutralizing confirmatory test when performed only for an initially reactive hbsag result 
G0500 Mod sedat endo service >5yrs Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153 as appropriate) 
G0501 Resource-inten svc during ov Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables patient lift and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient evaluation and management  visit (list separately in addition to primary service) 
G0502 Init psych care manag 70min Initial psychiatric collaborative care management first 70 minutes in the first calendar month of behavioral health care manager activities in consultation with a psychiatric consultant and directed by the treating physician or other qualified health care professional with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient including administration of validated rating scales with the development of an individualized treatment plan;  review by the psychiatric consultant with modifications of the plan if recommended;  entering patient in a registry and tracking patient follow-up and progress using the registry with appropriate documentation and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation motivational interviewing and other focused treatment strategies 
G0503 Subseq  psych care man60mi Subsequent psychiatric collaborative care management first 60 minutes in a subsequent month of behavioral health care manager activities in consultation with a psychiatric consultant and directed by the treating physician or other qualified health care professional with the following required elements:  tracking patient follow-up and progress using the registry with appropriate documentation;  participation in weekly caseload consultation with the psychiatric consultant;  ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers;  additional review of progress and recommendations for changes in treatment as indicated including medications based on recommendations provided by the psychiatric consultant;  provision of brief interventions using evidence-based techniques such as behavioral activation motivational interviewing and other focused treatment strategies;  monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment 
G0504 Init/sub psych care add 30 m Initial or subsequent psychiatric collaborative care management each additional 30 minutes in a calendar month of behavioral health care manager activities in consultation with a psychiatric consultant and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure);  (use g0504 in conjunction with g0502 g0503) 
G0505 Cog/func assessment  outpt Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment history obtained from patient and/or caregiver in office or other outpatient setting or home or domiciliary or rest home 
G0506 Comp asses care plan ccm svc Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) 
G0507 Care manage serv minimum 20 Care management services for behavioral health conditions at least 20 minutes of clinical staff time directed by a physician or other qualified health care professional per calendar month with the following required elements: initial assessment or follow-up monitoring including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy pharmacotherapy counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team 
G0508 Crit care telehea consult 60 Telehealth consultation critical care initial  physicians typically spend 60 minutes communicating with the patient and providers via telehealth 
G0509 Crit care telehea consult 50 Telehealth consultation critical care subsequent physicians typically spend 50 minutes communicating with the patient and providers via telehealth 
G0511 Ccm/bhi by rhc/fqhc 20min mo Rural health clinic or federally qualified health center (rhc or fqhc) only general care management 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician np pa or cnm) per calendar month 
G0512 Cocm by rhc/fqhc 60 min mo Rural health clinic or federally qualified health center (rhc/fqhc) only psychiatric collaborative care model (psychiatric cocm) 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician np pa or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant per calendar month 
G0513 Prolong prev svcs first 30m Prolonged preventive service(s) (beyond the typical service time of the primary procedure) in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service) 
G0514 Prolong prev svcs addl 30m Prolonged preventive service(s) (beyond the typical service time of the primary procedure) in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service) 
G0515 Cognitive skills development Development of cognitive skills to improve attention memory problem solving (includes compensatory training) direct (one-on-one) patient contact each 15 minutes 
G0516 Insert drug del implant >=4 Insertion of non-biodegradable drug delivery implants 4 or more (services for subdermal rod implant) 
G0517 Remove drug implant Removal of non-biodegradable drug delivery implants 4 or more (services for subdermal implants) 
G0518 Remove w insert drug implant Removal with reinsertion non-biodegradable drug delivery implants 4 or more (services for subdermal implants) 
G0659 Drug test def simple all cl Drug test(s) definitive utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers) including but not limited to gc/ms (any type single or tandem) and lc/ms (any type single or tandem) excluding immunoassays (e.g. ia eia elisa emit fpia) and enzymatic methods (e.g. alcohol dehydrogenase) performed without method or drug-specific calibration without matrix-matched quality control material or without use of stable isotope or other universally recognized internal standard(s) for each drug drug metabolite or drug class per specimen; qualitative or quantitative all sources includes specimen validity testing per day any number of drug classes 
G0908 Hgb > 12 g/dl Most recent hemoglobin (hgb) level > 12.0 g/dl 
G0909 Hbg not doc Hemoglobin level measurement not documented reason not given 
G0910 Hgb <= 12 g/dl Most recent hemoglobin level <= 12.0 g/dl 
G0913 Improve visual funct Improvement in visual function achieved within 90 days following cataract surgery 
G0914 Survey not complete Patient care survey was not completed by patient 
G0915 No improve visual funct Improvement in visual function not achieved within 90 days following cataract surgery 
G0916 Satisfy with care Satisfaction with care achieved within 90 days following cataract surgery 
G0917 Satisfy survey not complete Patient satisfaction survey was not completed by patient 
G0918 No satisfy with care Satisfaction with care not achieved within 90 days following cataract surgery 
G0919 Flu immunize not avail Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit 
G0920 Type loc act doc Type anatomic location and activity all documented 
G0921 Doc pt reas no assess Documentation of patient reason(s) for not being able to assess (e.g. patient refuses endoscopic and/or radiologic assessment) 
G0922 Type loc act not doc No documentation of disease type anatomic location and activity reason not given 
G1000 Cdsm applied pathways Clinical decision support mechanism applied pathways as defined by the medicare appropriate use criteria program 
G1001 Cdsm evicore Clinical decision support mechanism evicore as defined by the medicare appropriate use criteria program 
G1002 Cdsm medcurrent Clinical decision support mechanism medcurrent as defined by the medicare appropriate use criteria program 
G1003 Cdsm medicalis Clinical decision support mechanism medicalis as defined by the medicare appropriate use criteria program 
G1004 Cdsm ndsc Clinical decision support mechanism national decision support company as defined by the medicare appropriate use criteria program 
G1005 Cdsm nia Clinical decision support mechanism national imaging associates as defined by the medicare appropriate use criteria program 
G1006 Cdsm test approp Clinical decision support mechanism test appropriate as defined by the medicare appropriate use criteria program 
G1007 Cdsm aim Clinical decision support mechanism aim specialty health as defined by the medicare appropriate use criteria program 
G1008 Cdsm cranberry pk Clinical decision support mechanism cranberry peak as defined by the medicare appropriate use criteria program 
G1009 Cdsm sage health Clinical decision support mechanism sage health management solutions as defined by the medicare appropriate use criteria program 
G1010 Cdsm stanson Clinical decision support mechanism stanson as defined by the medicare appropriate use criteria program 
G1011 Cdsm qualified nos Clinical decision support mechanism qualified tool not otherwise specified as defined by the medicare appropriate use criteria program 
G2000 Blinded conv. tx mdd clin tr Blinded administration of convulsive therapy procedure either electroconvulsive therapy (ect current covered gold standard) or magnetic seizure therapy (mst non-covered experimental therapy) performed in an approved ide-based clinical trial per treatment session 
G2001 Post d/c h vst new pt 20 m Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2002 Post-d/c h vst new pt 30 m Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2003 Post-d/c h vst new pt 45 m Moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2004 Post-d/c h vst new pt 60 m Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2005 Post-d/c h vst new pt 75 m Extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2006 Post-d/c h vst ext pt 20 m Brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2007 Post-d/c h vst ext pt 30 m Limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2008 Post-d/c h vst ext pt 45 m Moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2009 Post-d/c h vst ext pt 60 m Comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2010 Remot image submit by pt Remote evaluation of recorded video and/or images submitted by an established patient (e.g. store and forward) including interpretation with follow-up with the patient within 24 business hours not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment 
G2011 Alcohol/sub abuse assess Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g. audit dast) and brief intervention 5-14 minutes 
G2012 Brief check in by md/qhp Brief communication technology-based service e.g. virtual check-in by a physician or other qualified health care professional who can report evaluation and management services provided to an established patient not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 
G2013 Post-d/c h vst ext pt 75 m Extensive (75 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2014 Post-d/c care plan overs 30m Limited (30 minutes) care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.) 
G2015 Post-d/c care plan overs 60m Comprehensive (60 mins) home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home domiciliary rest home assisted living and/or nursing facility within 90 days following discharge from an inpatient facility.) 
G2021 Hea care pract tx in place Health care practitioners rendering treatment in place (tip) 
G2022 Benef refuses service mod A model participant (ambulance supplier/provider) the beneficiary refuses services covered under the model (transport to an alternate destination/treatment in place) 
G2058 Ccm add 20min Chronic care management services each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490 g2058 in the same calendar month as 99487 99489 99491)). 
G2061 Qual nonmd est pt 5-10m Qualified nonphysician healthcare professional online assessment for an established patient for up to seven days cumulative time during the 7 days; 5-10 minutes 
G2062 Qual nonmd est pt 11-20m Qualified nonphysician healthcare professional online assessment service for an established patient for up to seven days cumulative time during the 7 days; 11-20 minutes 
G2063 Qual nonmd est pt 21>min Qualified nonphysician qualified healthcare professional assessment service for an established patient for up to seven days cumulative time during the 7 days; 21 or more minutes 
G2064 Md mang high risk dx 30 Comprehensive care management services for a single high-risk disease e.g. principal care management at least 30 minutes of physician  or other qualified health care professional  time per calendar month with the following elements: one complex chronic condition lasting  at least 3 months  which is the focus of the care plan the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization the condition requires development or revision of disease-specific care plan the condition requires frequent adjustments in the medication regimen and/or the management of the condition is unusually complex due to comorbidities 
G2065 Clin mang h risk dx 30 Comprehensive care management for a single high-risk disease services e.g. principal care management at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional per calendar month with the following elements: one complex chronic condition lasting at least 3 months which is the focus of the care plan the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization the condition requires development or revision of disease-specific care plan the condition requires frequent adjustments in the medication regimen and/or the management of the condition is unusually complex due to comorbidities 
G2066 Inter devc remote 30d Interrogation device evaluation(s) (remote) up to 30 days; implantable cardiovascular physiologic monitor system implantable loop recorder system or subcutaneous cardiac rhythm monitor system remote data acquisition(s) receipt of transmissions and technician review technical support and distribution of results 
G2067 Med assist tx meth wk Medication assisted treatment methadone; weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2068 Med assist tx bupre oral Medication assisted treatment buprenorphine (oral); weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2069 Med assist tx inject Medication assisted treatment buprenorphine (injectable); weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2070 Med assist tx implant Medication assisted treatment buprenorphine (implant insertion); weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2071 Med tx remove implant Medication assisted treatment buprenorphine (implant removal); weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2072 Med tx insert/remove imp Medication assisted treatment buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2073 Med tx naltrexone Medication assisted treatment naltrexone; weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2074 Med assist tx no drug Medication assisted treatment weekly bundle not including the drug including substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2075 Med tx meds nos Medication assisted treatment medication not otherwise specified; weekly bundle including dispensing and/or administration substance use counseling individual and group therapy and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) 
G2076 Intake act w/med exam Intake activities including initial medical examination that is a complete fully documented physical evaluation and initial assessment by a program physician or a primary care physician or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient's short-term goals and the tasks the patient must perform to complete the short-term goals; the patient's requirements for education vocational rehabilitation and employment; and the medical psycho- social economic legal or other supportive services that a patient needs conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure 
G2077 Periodic assessment Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure 
G2078 Take-home meth Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure 
G2079 Take-hom buprenorphine Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure 
G2080 Add 30 mins counsel Each additional 30 minutes of counseling in a week of medication assisted treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure 
G2081 Pt 66+ snp or ltc pos > 90d Patients age 66 and older in institutional special needs plans (snp) or residing in long-term care with a pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G2082 Visit esketamine 56m or less Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration includes 2 hours post-administration observation 
G2083 Visit esketamine > 56m Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of  greater than 56 mg esketamine nasal self-administration includes 2 hours post-administration observation 
G2086 Off base opioid tx 70min Office-based treatment for opioid use disorder including development of the treatment plan care coordination individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month 
G2087 Off base opioid tx 60 m Office-based treatment for opioid use disorder including care coordination individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month 
G2088 Off base opioid tx add30 Office-based treatment for opioid use disorder including care coordination individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure) 
G2089 A1c level 7 to 9% Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0% 
G2090 Pt 66+ frailty and med dem Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2091 Pt 66+ frailty and adv ill Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2092 Ace arb arni Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or currently being taken 
G2093 Med doc rsn no ace arn arni Documentation of medical reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g. hypotensive patients who are at immediate risk of cardiogenic shock hospitalized patients who have experienced marked azotemia allergy intolerance other medical reasons) 
G2094 Pt rsn no ace arn arni Documentation of patient reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g. patient declined other patient reasons) 
G2095 Sys rsn no ace arn arni Documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g. other system reasons) 
G2096 No rsn ace arb arni Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed reason not given 
G2097 Child dx uri 3d of other dx Children with a competing diagnosis for upper respiratory infection within three days of diagnosis of pharyngitis (e.g. intestinal infection pertussis bacterial infection lyme disease otitis media acute sinusitis acute pharyngitis acute tonsillitis chronic sinusitis infection of the pharynx/larynx/tonsils/adenoids prostatitis cellulitis mastoiditis or bone infections acute lymphadenitis impetigo skin staph infections pneumonia/gonococcal infections venereal disease (syphilis chlamydia inflammatory diseases [female reproductive organs]) infections of the kidney cystitis or uti 
G2098 Pt 66+ frailty and med dem Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2099 Pt 66+ frailty and adv ill Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2100 Pt 66+ frailty and med dem Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2101 Pt 66+ frailty and adv ill Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2102 Dil retinal eye exam Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed 
G2103 7 stereo photos interpret Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed 
G2104 Eye img valid w/7 stereo Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed 
G2105 Pt 66+ lt ints > 90 Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G2106 Pt 66+ lt ints > 90 Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2107 Pt 66+ frailty and adv ill Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2108 Pt 66+ lt ints > 90 Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G2109 Pt 66+ frailty and med dem Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2110 Pt 66+ frailty and adv ill Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2112 Pred<=5 mg ra glu <6m Patient receiving <=5 mg daily prednisone (or equivalent) or ra activity is worsening or glucocorticoid use is for less than 6 months 
G2113 Pred>5 mg >6m no chg da Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months and improvement or no change in disease activity 
G2114 Pt 66-80 frailty and med dem Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2115 Pt 66+ frailty and med dem Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2116 Pt 66+ frailty and adv ill Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2117 Pt 66-80 frailty and adv ill Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2118 Pt 81+ frailty Patients 81 years of age and older with a evidence of frailty during the measurement period 
G2119 Calc vitd opt Within the past 2 years calcium and/or vitamin d optimization has been ordered or performed 
G2120 No calc vitd opt Within the past 2 years calcium and/or vitamin d optimization has not been ordered or performed 
G2121 Psy dep anx ap and icd asse Psychosis depression anxiety apathy and impulse control disorder assessed 
G2122 Psy/dep/anx/apandicd noasse Psychosis depression anxiety apathy and impulse control disorder not assessed 
G2123 Pt 66-80 frailty med dem Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2124 Pt 66-80 frailty adv ill Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication 
G2125 Pt 81+ frailty Patients 81 years of age and older with evidence of frailty during the measurement period 
G2126 Pt 66+ frailty adv ill Patients 66 years of age or older and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2127 Pt 66+ frailty med dem Patients 66 years of age or older and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication 
G2128 No aspirin med rsn Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed intra-cranial bleed blood disorders idiopathic thrombocytopenic purpura (itp) gastric bypass or documentation of active anticoagulant use during the measurement period) 
G2129 No bp outpt Procedure-related bp's not taken during an outpatient visit. examples include same day surgery ambulatory service center g.i. lab dialysis infusion center chemotherapy 
G2130 Pt 66+ lt inst > 90 Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G2131 Pt 81+ frailty Patients 81 years and older with a diagnosis of frailty 
G2132 Pt 66-80 frailty and med dem Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2133 Pt 66-80 frailty and adv ill Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2134 Pt 66+ frailty and med dem Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period 
G2135 Pt 66+ frailty and adv ill Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient observation ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period 
G2136 Bk pain vas 6-20wk = 3 Back pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 ? 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater 
G2137 Bk pain vas 6-20wk > 3 Back pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 ? 20 weeks) postoperatively demonstrated a change of less than an improvement of 5.0 points 
G2138 Bk pain vas 9-15mo = 3 Back pain as measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of 5.0 points or greater 
G2139 Bk pain vas 9-20mo > 3 Back pain measured by the visual analog scale (vas) pain at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of less than 5.0 
G2140 Leg pain vas 6-20wk = 3 Leg pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater 
G2141 Leg pain vas 6-20wk > 3 Leg pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated less than an improvement of 5.0 points 
G2142 Fs odi 9-15mo postop<= 22 Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of 30 points or greater 
G2143 Fs odi 9-15mo > 22 Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of less than 30 points 
G2144 Fs odi 6-20wk postop > 22 Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 ? 20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated a change of 30 points or greater 
G2145 Fsodi 6-20wk >22 or chg 30pt Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 ? 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated a change of less than 30 points 
G2146 Leg pain vas 9-15mo <= 3 Leg pain as measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater 
G2147 Leg pain vas 9-15mo > 3 Leg pain measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated less than an improvement of 5.0 points 
G2148 Mpm used Performance met: multimodal pain management was used 
G2149 No mpm med rsn Documentation of medical reason(s) for not using multimodal pain management (e.g. allergy to multiple classes of analgesics intubated patient hepatic failure patient reports no pain during pacu stay other medical reason(s)) 
G2150 No mpm Performance not met: multimodal pain management was not used 
G2151 Dx degen neuro Patients with diagnosis of a degenerative neurological condition such as als ms parkinson's diagnosed at any time before or during the episode of care 
G2152 Res change sc =0 Performance met: the residual change score  is equal to or greater than 0 
G2153 Hosp dur meas pd In hospice or using hospice services during the measurement period 
G2154 Td 9 yrs start end meas Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period 
G2155 Hist contraindications Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) 
G2156 No prior td or hx contra Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) 
G2157 Pneum vacc 12 mo 60+ Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart with the first occurrence after the age of 60 before or during the measurement period 
G2158 Pneum vacc adv rx Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period 
G2159 No pneum vacc 12 mo 60+ Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period 
G2160 Herpzos 50+ Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period 
G2161 Adv rx zos Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period 
G2162 No herpzos 50+ Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period 
G2163 Infl vacc 07/01 to 06/30 Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period 
G2164 Adv rx infl vacc Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period 
G2165 No infl vacc 07/01 to 06/30 Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period 
G2166 No pt adm dx no neck fs prom Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit visual deficit motor deficit language barrier or low reading level and a suitable proxy/recorder is not available; patient self-discharged early; medical reason 
G2167 Res change sc < 0 Performance not met: the residual change score is less than 0 
G3001 Admin + supply tositumomab Administration and supply of tositumomab 450 mg 
G6001 Echo guidance radiotherapy Ultrasonic guidance for placement of radiation therapy fields 
G6002 Stereoscopic x-ray guidance Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy 
G6003 Radiation treatment delivery Radiation treatment delivery single treatment areasingle port or parallel opposed ports simple blocks or no blocks: up to 5 mev 
G6004 Radiation treatment delivery Radiation treatment delivery single treatment areasingle port or parallel opposed ports simple blocks or no blocks: 6-10 mev 
G6005 Radiation treatment delivery Radiation treatment delivery single treatment areasingle port or parallel opposed ports simple blocks or no blocks: 11-19 mev 
G6006 Radiation treatment delivery Radiation treatment delivery single treatment areasingle port or parallel opposed ports simple blocks or no blocks: 20 mev or greater 
G6007 Radiation treatment delivery Radiation treatment delivery 2 separate treatment areas 3 or more ports on a single treatment area use of multiple blocks: up to 5 mev 
G6008 Radiation treatment delivery Radiation treatment delivery 2 separate treatment areas 3 or more ports on a single treatment area use of multiple blocks: 6-10 mev 
G6009 Radiation treatment delivery Radiation treatment delivery 2 separate treatment areas 3 or more ports on a single treatment area use of multiple blocks: 11-19 mev 
G6010 Radiation treatment delivery Radiation treatment delivery 2 separate treatment areas 3 or more ports on a single treatment area use of multiple blocks: 20 mev or greater 
G6011 Radiation treatment delivery Radiation treatment delivery3 or more separate treatment areas custom blocking tangential ports wedges rotational beam compensators electron beam; up to 5 mev 
G6012 Radiation treatment delivery Radiation treatment delivery3 or more separate treatment areas custom blocking tangential ports wedges rotational beam compensators electron beam; 6-10 mev 
G6013 Radiation treatment delivery Radiation treatment delivery3 or more separate treatment areas custom blocking tangential ports wedges rotational beam compensators electron beam; 11-19 mev 
G6014 Radiation treatment delivery Radiation treatment delivery3 or more separate treatment areas custom blocking tangential ports wedges rotational beam compensators electron beam; 20 mev or greater 
G6015 Radiation tx delivery imrt Intensity modulated treatment delivery single or multiple fields/arcsvia narrow spatially and temporally modulated beams binary dynamic mlc per treatment session 
G6016 Delivery comp imrt Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator convergent beam modulated fields per treatment session 
G6017 Intrafraction track motion Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg3d positional tracking gating 3d surface tracking) each fraction of treatment 
G6018 Ileoscopy w/stent Ileoscopy through stoma; with transendoscopic stent placement (includes predilation) 
G6019 Colonoscopy lesion removal Colonoscopy through stoma; with ablation of tumor(s) polyp(s) or other lesion(s) not amenable to removal by hot biopsy forceps bipolar cautery or snare technique 
G6020 Colonoscopy w/stent Colonoscopy through stoma; with transendoscopic stent placement (includes predilation) 
G6021 Unlisted px small intestine Unlisted procedure intestine 
G6022 Sigmoidoscopy w/ablate tumr Sigmoidoscopy flexible; with ablation of tumor(s) polyp(s) or other lesions(s) not amenable to removal by hot biopsy forceps bipolar cautery or snare technique 
G6023 Sigmoidoscopy w/stent Sigmoidoscopy flexible; with transendoscopic stent placement (includes predilation) 
G6024 Lesion removal colonoscopy Colonoscopy flexible; proximal to splenic flexure; with ablation of tumor(s) polyp(s) or other lesion(s) not amenable to removal by hot biopsy forceps bipolar cautery or snare technique 
G6025 Colonoscopy w/stent Colonoscopy flexible proximal to splenic flexure; with transendoscopic stent placement (includes predilation) 
G6027 Anoscopy hra w/spec collect Anoscopy high resolution (hra) (with magnification and chemical agent enhancement); diagnostic including collection of specimen(s) by brushing or washing when performed 
G6028 Anoscopy hra w/biopsy Anoscopy high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) 
G6030 Assay of amitriptyline Amitriptyline 
G6031 Assay of benzodiazepines Benzodiazepines 
G6032 Assay of desipramine Desipramine 
G6034 Assay of doxepin Doxepin 
G6035 Assay of gold Gold 
G6036 Assay of imipramine Assay of imipramine 
G6037 Assay of nortiptyline Nortriptyline 
G6038 Assay of salicylate Salicylate 
G6039 Assay of acetaminophen Acetaminophen 
G6040 Assay of ethanol Alcohol (ethanol); any specimen except breath 
G6041 Assay of urine alkaloids Alkaloids urine quantitative 
G6042 Assay of amphetamines Amphetamine or methamphetamine 
G6043 Assay of barbiturates Barbiturates not elsewhere specified 
G6044 Assay of cocaine Cocaine or metabolite 
G6045 Assay of dihydrocodeinone Dihydrocodeinone 
G6046 Assay of dihydromorphinone Dihydromorphinone 
G6047 Assay of dihydrotestosterone Dihydrotestosterone 
G6048 Assay of dimethadione Dimethadione 
G6049 Asssay of epiandrosterone Epiandrosterone 
G6050 Assay of ethchlorvynol Ethchlorvynol 
G6051 Assay of flurazepam Flurazepam 
G6052 Assay of meprobamate Meprobamate 
G6053 Assay of methadone Methadone 
G6054 Assay of methsuximide Methsuximide 
G6055 Assay of nicotine Nicotine 
G6056 Assay of opiates Opiate(s) drug and metabolites each procedure 
G6057 Assay of phenothiazine Phenothiazine 
G6058 Drug confirmation Drug confirmation each procedure 
G8126 Pt treat w/antidepress12wks Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week)  acute treatment phase 
G8127 Pt not treat w/antidepres12w Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase 
G8128 Pt inelig for antidepres med Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure 
G8395 Lvef>=40% doc normal or mild Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function 
G8396 Lvef not performed Left ventricular ejection fraction (lvef) not performed or documented 
G8397 Dil macula/fundus exam/w doc Dilated macular or fundus exam performed including documentation of the presence or absence of macular edema and level of severity of retinopathy 
G8398 Dil macular/fundus not perfo Dilated macular or fundus exam not performed 
G8399 Pt w/dxa results document Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed 
G8400 Pt w/dxa no results doc Patient with central dual-energy x-ray absorptiometry (dxa) results not documented reason not given 
G8401 Pt inelig osteo screen measu Clinician documented that patient was not an eligible candidate for screening 
G8404 Low extemity neur exam docum Lower extremity neurological exam performed and documented 
G8405 Low extemity neur not perfor Lower extremity neurological exam not performed 
G8406 Pt inelig lower extrem neuro Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure 
G8410 Eval on foot documented Footwear evaluation performed and documented 
G8415 Eval on foot not performed Footwear evaluation was not performed 
G8416 Pt inelig footwear evaluatio Clinician documented that patient was not an eligible candidate for footwear evaluation measure 
G8417 Calc bmi abv up param f/u Bmi is documented above normal parameters and a follow-up plan is documented 
G8418 Calc bmi blw low param f/u Bmi is documented below normal parameters and a follow-up plan is documented 
G8419 Calc bmi out nrm param nof/u Bmi documented outside normal parameters no follow-up plan documented no reason given 
G8420 Calc bmi norm parameters Bmi is documented within normal parameters and no follow-up plan is required 
G8421 Bmi not calculated Bmi not documented and no reason is given 
G8422 Pt inelig bmi calculation Bmi not documented documentation the patient is not eligible for bmi calculation 
G8427 Docrev cur meds by elig clin Eligible clinician attests to documenting in the medical record they obtained updated or reviewed the patient's current medications 
G8428 Cur meds not document Current list of medications not documented as obtained updated or reviewed by the eligible clinician reason not given 
G8430 Ec at doc medrec pt not elig Eligible clinician attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained updated or reviewed by the eligible clinician 
G8431 Pos clin depres scrn f/u doc Screening for depression is documented as being positive and a follow-up plan is documented 
G8432 Dep scr not doc rng Depression screening not documented reason not given 
G8433 Scr for dep not cpt doc rsn Screening for depression not completed documented reason 
G8442 Doc pain as nt perf not elg Pain assessment not documented as being performed documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter 
G8450 Beta-bloc rx pt w/abn lvef Beta-blocker therapy prescribed 
G8451 Pt w/abn lvef inelig b-bloc Beta-blocker therapy for lvef < 40% not prescribed for reasons documented by the clinician (e.g. low blood pressure fluid overload asthma patients recently treated with an intravenous positive inotropic agent allergy intolerance other medical reasons patient declined other patient reasons or other reasons attributable to the healthcare system) 
G8452 Pt w/abn lvef b-bloc no rx Beta-blocker therapy not prescribed 
G8458 Pt inelig geno no antvir tx Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period patient declines patient not a candidate for antiviral treatment) 
G8460 Pt inelig rna no antvir tx Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c 
G8461 Pt rec antivir treat hep c Patient receiving antiviral treatment for hepatitis c during the measurement period 
G8464 Pt inelig; lo to no dter rsk Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined 
G8465 High risk recurrence pro ca High or very high risk of recurrence of prostate cancer 
G8473 Ace/arb thxpy rx'd Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed 
G8474 Ace/arb not rx'd; doc reas Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g. allergy intolerance pregnancy renal failure due to ace inhibitor diseases of the aortic or mitral valve other medical reasons) or (e.g. patient declined other patient reasons) or (e.g. lack of drug availability other reasons attributable to the health care system) 
G8475 Ace/arb thxpy not rx'd Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed reason not given 
G8476 Bp sys <140 and dias <90 Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg 
G8477 Bp sys>=140 and/or dias >=90 Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg 
G8478 Bp not performed/doc Blood pressure measurement not performed or documented reason not given 
G8482 Flu immunize order/admin Influenza immunization administered or previously received 
G8483 Flu imm no admin doc rea Influenza immunization was not administered for reasons documented by clinician (e.g. patient allergy or other medical reasons patient declined or other patient reasons vaccine not available or other system reasons) 
G8484 Flu immunize no admin Influenza immunization was not administered reason not given 
G8485 Report diabetes measures I intend to report the diabetes mellitus (dm) measures group 
G8486 Report prev care measures I intend to report the preventive care measures group 
G8487 Report ckd measures I intend to report the chronic kidney disease (ckd) measures group 
G8489 Cad measures grp I intend to report the coronary artery disease (cad) measures group 
G8490 Ra measures grp I intend to report the rheumatoid arthritis (ra) measures group 
G8491 Hiv/aids measures grp I intend to report the hiv/aids measures group 
G8492 Periop care measures grp I intend to report the perioperative care measures group 
G8493 Back pain measures grp I intend to report the back pain measures group 
G8494 Dm meas qual act perform All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient 
G8495 Ckd meas qual act perform All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient 
G8496 Prev care mg qual act perfrm All quality actions for the applicable measures in the preventive care measures group have been performed for this patient 
G8497 Cabg meas qual act perform All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient 
G8498 Cad meas qual act perform All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient 
G8499 Ra meas qual act perform All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient 
G8500 Hiv meas qual act perform All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient 
G8501 Perio meas qual act perform All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient 
G8502 Back pain mg qual act perfrm All quality actions for the applicable measures in the back pain measures group have been performed for this patient 
G8506 Pt rec ace/arb Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy 
G8509 Pos pain assess no f/u doc Pain assessment documented as positive using a standardized tool follow-up plan not documented reason not given 
G8510 Scr dep neg no plan reqd Screening for depression is documented as negative a follow-up plan is not required 
G8511 Scr dep pos no plan doc rng Screening for depression documented as positive follow-up plan not documented reason not given 
G8530 Auto av fistula recd Autogenous av fistula received 
G8531 Pt inelig; auto av fistula Clinician documented that patient was not an eligible candidate for autogenous av fistula 
G8532 No auto av fistula; no reas Clinician documented that patient received vascular access other than autogenous av fistula reason not given 
G8535 Eld maltreatment not doc Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter 
G8536 No doc elder mal scrn No documentation of an elder maltreatment screen reason not given 
G8539 Doc funct and care plan Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies on the date of functional outcome assessment is documented 
G8540 Foa not doc as being perf Functional outcome assessment not documented as being performed documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter 
G8541 No doc cur funct assess Functional outcome assessment using a standardized tool not documented reason not given 
G8542 Doc funct no deficiencies Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified care plan not required 
G8543 Cur funct asses; no care pln Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented reason not given 
G8544 Cabg measures grp I intend to report the coronary artery bypass graft (cabg) measures group 
G8545 Hepc measures grp I intend to report the hepatitis c measures group 
G8547 Ivd measures grp I intend to report the ischemic vascular disease (ivd) measures group 
G8548 Hf measures grp I intend to report the heart failure (hf) measures group 
G8549 Hepc mg qual act perform All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient 
G8551 Hf mg qual act perform All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient 
G8552 Ivd mg qual act perform All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient 
G8559 Pt ref doc oto eval Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation 
G8560 Pt hx act drain prev 90 days Patient has a history of active drainage from the ear within the previous 90 days 
G8561 Pt inelig for ref oto eval Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure 
G8562 Pt no hx act drain 90 d Patient does not have a history of active drainage from the ear within the previous 90 days 
G8563 Pt no ref oto reas no spec Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation reason not given 
G8564 Pt ref oto eval Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation reason not specified) 
G8565 Ver doc hear loss Verification and documentation of sudden or rapidly progressive hearing loss 
G8566 Pt inelig ref oto eval Patient is not eligible for the "referral for otologic evaluation for sudden or rapidly progressive hearing loss" measure 
G8567 Pt no doc hear loss Patient does not have verification and documentation of sudden or rapidly progressive hearing loss 
G8568 Pt no ref otolo no spec Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation reason not given 
G8569 Prol intubation req Prolonged postoperative intubation (> 24 hrs) required 
G8570 No prol intub req Prolonged postoperative intubation (> 24 hrs) not required 
G8571 Ster wd ifx 30 d postop Development of deep sternal wound infection/mediastinitis within 30 days postoperatively 
G8572 No ster wd ifx No deep sternal wound infection/mediastinitis 
G8573 Stk cabg Stroke following isolated cabg surgery 
G8574 No strk cabg No stroke following isolated cabg surgery 
G8575 Postop ren fail Developed postoperative renal failure or required dialysis 
G8576 No postop ren fail No postoperative renal failure/dialysis not required 
G8577 Reop req bld grft oth Re-exploration required due to mediastinal bleeding with or without tamponade graft occlusion valve dysfunction or other cardiac reason 
G8578 No reop req bld grft oth Re-exploration not required due to mediastinal bleeding with or without tamponade graft occlusion valve dysfunction or other cardiac reason 
G8579 Antplt med disch Antiplatelet medication at discharge 
G8580 Antplt med contraind Antiplatelet medication contraindicated 
G8581 No antplt med disch No antiplatelet medication at discharge 
G8582 Bblock disch Beta-blocker at discharge 
G8583 Bblock contraind Beta-blocker contraindicated 
G8584 No bblock disch No beta-blocker at discharge 
G8585 Antilipid treat disch Anti-lipid treatment at discharge 
G8586 Antlip disch contra Anti-lipid treatment contraindicated 
G8587 No antlipid treat disch No anti-lipid treatment at discharge 
G8593 Lipid pn results Lipid profile results documented and reviewed (must include total cholesterol hdl-c triglycerides and calculated ldl-c) 
G8594 No lipid prof perf Lipid profile not performed reason not given 
G8595 Ldl < 100 Most recent ldl-c < 100 mg/dl 
G8597 Ldl >= 100 Most recent ldl-c >= 100 mg/dl 
G8598 Asa/antiplat ther used Aspirin or another antiplatelet therapy used 
G8599 No asa/antiplat ther use rng Aspirin or another antiplatelet therapy not used reason not given 
G8600 Tpa initi w/in 3 hrs Iv t-pa initiated within three hours (<= 180 minutes) of time last known well 
G8601 No elig tpa init w/in 3 hrs Iv t-pa not initiated within three hours (<= 180 minutes) of time last known well for reasons documented by clinician 
G8602 No tpa init w/in 3 hrs Iv t-pa not initiated within three hours (<= 180 minutes) of time last known well reason not given 
G8627 Surg proc w/in 30 days Surgical procedure performed within 30 days following cataract surgery for major complications (e.g. retained nuclear fragments endophthalmitis dislocated or wrong power iol retinal detachment or wound dehiscence) 
G8628 No surg proc w/in 30 days Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g. retained nuclear fragments endophthalmitis dislocated or wrong power iol retinal detachment or wound dehiscence) 
G8629 Doc antibio order b/4 surg Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin two hours) prior to surgical incision (or start of procedure when no incision is required) 
G8630 Doc antibio given b/4 surg Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin two hours) prior to surgical incision (or start of procedure when no incision is required) as ordered 
G8631 Pt no elg 4 order antbi give Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin two hours) prior to surgical incision (or start of procedure when no incision is required) 
G8632 Doc no antibi order b/4 surg Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin two hours) prior to the surgical incision (or start of procedure when no incision is required) reason not given 
G8633 Pharm ther osteo rx Pharmacologic therapy (other than minierals/vitamins) for osteoporosis prescribed 
G8634 Pt no elg phar ther osteo Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis 
G8635 No pharm ther osteo rx Pharmacologic therapy for osteoporosis was not prescribed reason not given 
G8645 Asthma measures grp I intend to report the asthma measures group 
G8646 Asthma mg qual act perform All quality actions for the applicable measures in the asthma measures group have been performed for this patient 
G8647 Rafscrs ki scor >= 0 Risk-adjusted functional status change residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0) 
G8648 Rafscrs ki scor < 0 Risk-adjusted functional status change residual score for the knee impairment successfully calculated and the score was less than zero (< 0) 
G8649 Rafscrs ki no scor Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge patient not appropriate 
G8650 Rafs crs ki no scor no surv Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the knee fs prom at initial evaluation  and/or near discharge reason not given 
G8651 Rafscrs hi scor >=0 Risk-adjusted functional status change residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0) 
G8652 Rafscrs hi scor < 0 Risk-adjusted functional status change residual score for the hip impairment successfully calculated and the score was less than zero (< 0) 
G8653 Rafscrs hi no scor Risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge patient not appropriate 
G8654 Rafs crs hi no scor no surv Risk-adjusted functional status change residual score for the hip impairment not measured because the patient did not complete the fs intake survey on admission and/or follow up fs status survey near discharge reason not given 
G8655 Rafscrs llfai scor >= 0 Risk-adjusted functional status change residual score for the lower leg foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( > 0) 
G8656 Rafscrs llfai scor < 0 Risk-adjusted functional status change residual score for the lower leg foot or ankle impairment successfully calculated and the score was less than zero (< 0) 
G8657 Rafscrs llfai no scor Risk-adjusted functional status change residual score for the lower leg foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge patient not appropriate 
G8658 Rafscrs llfai no scor + surv Risk-adjusted functional status change residual score for the lower leg foot or ankle impairment not measured because the patient did not complete the fs intake survey on admission and/or follow up fs status survey near discharge reason not given 
G8659 Rafscrs lbi scor >= 0 Risk-adjusted functional status change residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0) 
G8660 Rafscrs lbi scor < 0 Risk-adjusted functional status change residual score for the low back impairment successfully calculated and the score was less than zero (< 0) 
G8661 Rafscrs lbi no scor Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge patient not appropriate 
G8662 Rafs crs lbi no scor no surv Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the low back fs prom at initial evaluation and/or near discharge reason not given 
G8663 Rafscrs si scor >= 0 Risk-adjusted functional status change residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0) 
G8664 Rafscrs si scor < 0 Risk-adjusted functional status change residual score for the shoulder impairment successfully calculated and the score was less than zero (< 0) 
G8665 Rafscrs si no scor Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge patient not appropriate 
G8666 Rafs crs si no scor no surv Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the shoulder fs prom at initial evaluation and/or near discharge reason not given 
G8667 Rafscrs ewh scor >= 0 Risk-adjusted functional status change residual score for the elbow wrist or hand impairment  successfully calculated and the score was equal to zero (0) or greater than zero (> 0) 
G8668 Rafscrs ewh scor < 0 Risk-adjusted functional status change residual score for the elbow wrist or hand impairment  successfully calculated and the score was less than zero (< 0) 
G8669 Rafscrs Risk-adjusted functional status change residual score for the elbow wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge patient not appropriate 
G8670 Rafs crs ewh no scor no surv Risk-adjusted functional status change residual score for the elbow wrist or hand impairment not measured because the patient did not complete the elbow/wrist/hand fs prom at initial evaluation and/or near discharge reason not given 
G8671 Rafscrs goi scor >= 0 Risk-adjusted functional status change residual score for the neck cranium mandible thoracic spine ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0) 
G8672 Rafscrs goi scor < 0 Risk-adjusted functional status change residual score for the neck cranium mandible thoracic spine ribs or other general orthopedic impairment successfully calculated and the score was less than zero (< 0) 
G8673 Rafscrs goi no scor Risk-adjusted functional status change residual score for the neck cranium mandible thoracic spine ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge patient not appropriate 
G8674 Rafscrs neck no msr/no foto Risk-adjusted functional status change residual score for the neck cranium mandible thoracic spine ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge reason not given 
G8682 Lvg test perf Lvf testing documented as being performed prior to discharge or in the previous 12 months 
G8683 Pt not elig for lvf test Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason 
G8685 Lvf test not perf Lvf testing not documented as being performed prior to discharge or in the previous 12 months reason not given 
G8694 Lvef <40% Left ventricular ejection fraction (lvef) < 40% 
G8696 Antithromb thx presc Antithrombotic therapy prescribed at discharge 
G8697 Antithromb no presc doc reas Antithrombotic therapy not prescribed for documented reasons (e.g. patient had stroke during hospital stay patient expired during inpatient stay other medical reason(s)); (e.g. patient left against medical advice other patient reason(s)) 
G8698 Antithromb no presc no reas Antithrombotic therapy was not prescribed at discharge reason not given 
G8699 Rehab ordered disch Rehabilitation services (occupational physical or speech) ordered at or prior to discharge 
G8700 Rehab not indicated disch Rehabilitation services (occupational physical or speech) not indicated at or prior to discharge 
G8701 Rehab not ordered Rehabilitation services were not ordered reason not otherwise specified 
G8702 Antiobiotics 4 hr prior surg Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively 
G8703 Antibiotics not prior surg Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively 
G8704 Ecg performed 12-lead electrocardiogram (ecg) performed 
G8705 Med reas no ecg Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) 
G8706 Pt reas no ecg Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg) 
G8707 Ecg not performed 12-lead electrocardiogram (ecg) not performed reason not given 
G8708 Antibiotic not pres Patient not prescribed or dispensed antibiotic 
G8709 Pt presc doc med rsn id uri Patient prescribed or dispensed antibiotic for documented medical reason(s) within three days after the initial diagnosis of uri (e.g. intestinal infection pertussis bacterial infection lyme disease otitis media acute sinusitis acute pharyngitis acute tonsillitis chronic sinusitis infection of the pharynx/larynx/tonsils/adenoids prostatitis cellulitis mastoiditis or bone infections acute lymphadenitis impetigo skin staph infections pneumonia/gonococcal infections venereal disease (syphilis chlamydia inflammatory diseases (female reproductive organs)) infections of the kidney cystitis or uti and acne) 
G8710 Pt pres antibiotic Patient prescribed or dispensed antibiotic 
G8711 Pres antibiotic Prescribed or dispensed antibiotic 
G8712 Not pres antibiotic Antibiotic not prescribed or dispensed 
G8713 Spkt/v great 1.2 kt/v Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) 
G8714 Hemodialysis 3 times week Hemodialysis treatment performed exactly three times per week for > 90 days 
G8717 Less 1.2 kt/v Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]) reason not given 
G8718 Great 1.7 kt/v per week Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v]) 
G8720 Less 1.7 kt/v per week Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) 
G8721 Pt pn hist grade doc Pt category (primary tumor) pn category (regional lymph nodes) and histologic grade were documented in pathology report 
G8722 Med reas pt pn not doc Documentation of medical reason(s) for not including the pt category the pn category or the histologic grade in the pathology report (e.g. re-excision without residual tumor; non-carcinomasanal canal) 
G8723 Spec sit not prim tumor Specimen site is other than anatomic location of primary tumor 
G8724 Pt pn hist grade not doc Pt category pn category and histologic grade were not documented in the pathology report reason not given 
G8725 Lipid profile perf doc Fasting lipid profile performed (triglycerides ldl-c hdl-c and total cholesterol) 
G8726 Doc reas no lipid profile Clinician has documented reason for not performing fasting lipid profile (e.g. patient declined other patient reasons) 
G8728 Lipid profile not perf Fasting lipid profile not performed reason not given 
G8730 Pain doc pos and plan Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 
G8731 Pain neg no plan Pain assessment using a standardized tool is documented as negative no follow-up plan required 
G8732 No doc of pain No documentation of pain assessment reason not given 
G8733 Doc pos elder mal scrn plan Elder maltreatment screen documented as positive and a follow-up plan is documented 
G8734 Doc neg elder mal no plan Elder maltreatment screen documented as negative no follow-up required 
G8735 Eld mal scrn pos no plan Elder maltreatment screen documented as positive follow-up plan not documented reason not given 
G8736 Ldl-c <100mg/dl Most current ldl-c <100mg/dl 
G8737 Ldl-c >=100mg/dl Most current ldl-c >=100mg/dl 
G8738 Lvef < 40% Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function 
G8739 Lvef >= 40% Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function 
G8740 Lvef not perfrmd Left ventricular ejection fraction (lvef) not performed or assessed reason not given 
G8749 No signs melanoma Absence of signs of melanoma (tenderness jaundice localized neurologic signs such as weakness or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough dyspnea pain paresthesia or any other symptom suggesting the possibility of systemic spread of melanoma) 
G8751 Smkg status not assess Smoking status and exposure to second hand smoke in the home not assessed reason not given 
G8752 Sys bp less 140 Most recent systolic blood pressure < 140 mmhg 
G8753 Sys bp > or = 140 Most recent systolic blood pressure >= 140 mmhg 
G8754 Dias bp less 90 Most recent diastolic blood pressure < 90 mmhg 
G8755 Dias bp > or = 90 Most recent diastolic blood pressure >= 90 mmhg 
G8756 No bp measure doc No documentation of blood pressure measurement reason not given 
G8757 Copd mg qual act perform All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient 
G8758 Ibd mg qual act perform All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient 
G8759 Osa mg qual act perform All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient 
G8761 Dementia mg qual act perform All quality actions for the applicable measures in the dementia measures group have been performed for this patient 
G8762 Pd mg qual act perform All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient 
G8763 Hyperten mg qual act perform All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient 
G8764 Car prev mg qual act perform All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient 
G8765 Cataract mg qual act perform All quality actions for the applicable measures in the cataract measures group have been performed for this patient 
G8767 Lipid panel res doc rev Lipid panel results documented and reviewed (must include total cholesterol hdl-c triglycerides and calculated ldl-c) 
G8768 Doc med reas no lipid profle Documentation of medical reason(s) for not performing lipid profile (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) 
G8769 Lipid profile not perform Lipid profile not performed reason not given 
G8770 Urine protein test doc rev Urine protein test result documented and reviewed 
G8771 Doc dx ckd Documentation of diagnosis of chronic kidney disease 
G8772 Doc med reas no urine protn Documentation of medical reason(s) for not performing urine protein test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate) 
G8773 No urine protein test Urine protein test was not performed reason not given 
G8774 Serum creatinine doc rev Serum creatinine test result documented and reviewed 
G8775 Doc med reas no serum crtn Documentation of medical reason(s) for not performing serum creatinine test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) 
G8776 No serum creatinine test Serum creatinine test not performed reason not given 
G8777 Diabetes screen Diabetes screening test performed 
G8778 Doc med reas no diabete scrn Documentation of medical reason(s) for not performing diabetes screening test (e.g. patients with a diagnosis of diabetes or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) 
G8779 No diabetes screen Diabetes screening test not performed reason not given 
G8780 Counsel diet phys activity Counseling for diet and physical activity performed 
G8781 Doc med reas no counsel diet Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) 
G8782 No counsel diet phys act Counseling for diet and physical activity not performed reason not given 
G8783 Bp scrn perf rec interval Normal blood pressure reading documented follow-up not required 
G8784 Pt no elig for bp assess Patient not eligible (e.g. documentation the patient is not eligible due to active diagnosis of hypertension patient refuses urgent or emergent situation) 
G8785 Bp scrn no perf at interval Blood pressure reading not documented reason not given 
G8797 Specimen site not esophagus Specimen site other than anatomic location of esophagus 
G8798 Specimen site not prostate Specimen site other than anatomic location of prostate 
G8806 Perf ultrsnd to lct preg doc Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented 
G8807 No ta tv ultrasnd Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g. patient has visited the ed multiple times within 72 hours patient has a documented intrauterine pregnancy [iup]) 
G8808 Ultrasound not perf rng Trans-abdominal or trans-vaginal ultrasound not performed reason not given 
G8809 Rh-immunoglobulin order Rh-immunoglobulin (rhogam) ordered 
G8810 Doc reas no rh-immuno Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g. patient had prior documented receipt of rhogam within 12 weeks patient refusal) 
G8811 No rh-immunoglobulin order Documentation rh-immunoglobulin (rhogam) was not ordered reason not given 
G8815 Doc reas no statin therapy Documented reason in the medical records for why the statin therapy was not prescribed (i.e. lower extremity bypass was for a patient with non-artherosclerotic disease) 
G8816 Statin med pres at disch Statin medication prescribed at discharge 
G8817 Doc reas no statin med disch Statin therapy not prescribed at discharge reason not given 
G8818 Pt disch to home by day#7 Patient discharge to home no later than post-operative day #7 
G8825 Pt not disch to home day#7 Patient not discharged to home by post-operative day #7 
G8826 Pt disch home day #2 evar Patient discharge to home no later than post-operative day #2 following evar 
G8833 Pt not disch home day#2 evar Patient not discharged to home by post-operative day #2 following evar 
G8834 Pt disch home day #2 cea Patient discharged to home no later than post-operative day #2 following cea 
G8838 Not disch home by day #2 Patient not discharged to home by post-operative day #2 following cea 
G8839 Sleep apnea assess Sleep apnea symptoms assessed including presence or absence of snoring and daytime sleepiness 
G8840 Doc reas no sleep apnea Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g. patient didn't have initial daytime sleepiness patient visited between initial testing and initiation of therapy) 
G8841 No sleep apnea assess Sleep apnea symptoms not assessed reason not given 
G8842 Ahi or rdi initial dx Apnea hypopnea index (ahi) or respiratory disturbance index (rdi) measured at the time of initial diagnosis 
G8843 Doc reas no ahi or rdi Documentation of reason(s) for not measuring an apnea hypopnea index (ahi) or a respiratory disturbance index (rdi) at the time of initial diagnosis (e.g. psychiatric disease dementia patient declined financial insurance coverage test ordered but not yet completed) 
G8844 No ahi or rdi initial dx Apnea hypopnea index (ahi) or respiratory disturbance index (rdi) not measured at the time of initial diagnosis reason not given 
G8845 Pos airway press prescribed Positive airway pressure therapy prescribed 
G8846 Mod or severe osa Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater) 
G8848 Mild osa Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15) 
G8849 Doc reas no pos air press Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g. patient unable to tolerate alternative therapies use patient declined financial insurance coverage) 
G8850 No pap prescribed Positive airway pressure therapy not prescribed reason not given 
G8851 Adhere pos air press therapy Objective measurement of adherence to positive airway pressure therapy documented 
G8852 Pos air press prescribe Positive airway pressure therapy prescribed 
G8853 Pos air press not prescribe Positive airway pressure therapy not prescribed 
G8854 Reas no adhere pos air pres Documentation of reason(s) for not objectively measuring adherence to positive airway pressure therapy (e.g. patient didn't bring data from continous positive airway pressure [cpap] therapy not yet initiated not available on machine) 
G8855 Pos air press adhere no perf Objective measurement of adherence to positive airway pressure therapy not performed reason not given 
G8856 Ref for oto eval Referral to a physician for an otologic evaluation performed 
G8857 No elig ref for oto eval Patient is not eligible for the referral for otologic evaluation measure (e.g. patients who are already under the care of a physician for acute or chronic dizziness) 
G8858 Not ref for oto eval Referral to a physician for an otologic evaluation not performed reason not given 
G8859 Corticosteroids 10mg 60 days Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days 
G8860 Corticosteroid 10 mg 60 days Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days 
G8861 Dxa ordered for osteo Within the past 2 years central dual-energy x-ray absorptiometry (dxa) ordered and documented review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed 
G8862 No corticostrd 10mg 60 days Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days 
G8863 No assess bone loss Patients not assessed for risk of bone loss reason not given 
G8864 Pneumococcal vaccine admin Pneumococcal vaccine administered or previously received 
G8865 Doc med reas no pneumococcal Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g. patient allergic reaction potential adverse drug reaction) 
G8866 Doc pt reas no pneumococcal Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g. patient refusal) 
G8867 No pneumococcal admin Pneumococcal vaccine not administered or previously received reason not given 
G8868 1st course antitnf Patients receiving a first course of anti-tnf therapy 
G8869 Doc immune hep b antitnf Patient has documented immunity to hepatitis b and initiating anti-tnf therapy 
G8870 Hepb admin 1st antitnf Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy 
G8871 No 1st antitnf Patient not receiving a first course of anti-tnf therapy 
G8872 Intraop image confirm excise Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion 
G8873 Specimen not intraop image Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g. needle biopsy site where the biopsy marker is remote from the actual biopsy site) 
G8874 Tissue not image intraop Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion 
G8875 Breast cancer dx min invsive Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method 
G8876 Doc reas no min inv dx Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g. lesion too close to skin implant chest wall etc. lesion could not be adequately visualized for needle biopsy patient condition prevents needle biopsy [weight breast thickness etc.] duct excision without imaging abnormality prophylactic mastectomy reduction mammoplasty excisional biopsy performed by another physician) 
G8877 No brst cncr dx min invasive Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method reason not given 
G8878 Sent lymph node biopsy Sentinel lymph node biopsy procedure performed 
G8879 Node neg inv brst cncr Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer 
G8880 Sen lym p node biop not perf Documentation of reason(s) sentinel lymph node biopsy not performed (e.g. reasons could include but not limited to; non-invasive cancer incidental discovery of breast cancer on prophylactic mastectomy incidental discovery of breast cancer on reduction mammoplasty pre-operative biopsy proven lymph node (ln) metastases inflammatory carcinoma stage 3 locally advanced cancer recurrent invasive breast cancer clinically node positive after neoadjuvant systemic therapy patient refusal after informed consent patient with significant age comorbidities or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change) 
G8881 Brst cncr stage > t1n0m0 Stage of breast cancer is greater than t1n0m0 or t2n0m0 
G8882 No sent lymph node biopsy Sentinel lymph node biopsy procedure not performed reason not given 
G8883 Rev comm track doc biopsy Biopsy results reviewed communicated tracked and documented 
G8884 Doc reas biopsy not review Clinician documented reason that patient's biopsy results were not reviewed 
G8885 No rev comm track biopsy Biopsy results not reviewed communicated tracked or documented 
G8886 Bp under control Most recent blood pressure under control 
G8887 Doc med reas bp not control Documentation of medical reason(s) for most recent blood pressure not being under control (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) 
G8888 Bp not under control Most recent blood pressure not under control results documented and reviewed 
G8889 No doc bp No documentation of blood pressure measurement reason not given 
G8890 Ldl-c under control Most recent ldl-c under control results documented and reviewed 
G8891 Doc med reas no ldl-c contrl Documentation of medical reason(s) for most recent ldl-c not under control (e.g. patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate) 
G8892 Doc med reas no ldl-c test Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) 
G8893 Ldl-c not under control Most recent ldl-c not under control results documented and reviewed 
G8894 Ldl-c not performed Ldl-c not performed reason not given 
G8895 Antrom prescribe Oral aspirin or other antithrombotic therapy prescribed 
G8896 Doc med reas no antihtrom Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g. patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled) 
G8897 Antithrom not prescribe Oral aspirin or other antithrombotic therapy was not prescribed reason not given 
G8898 Copd measures group I intend to report the chronic obstructive pulmonary disease (copd) measures group 
G8899 Inflammatory bowel dis mg I intend to report the inflammatory bowel disease (ibd) measures group 
G8900 Obstructive sleep apnea mg I intend to report the sleep apnea measures group 
G8902 Dementia measures group I intend to report the dementia measures group 
G8903 Parkinson's disease mg I intend to report the parkinson's disease measures group 
G8904 Hypertension mg I intend to report the hypertension (htn) measures group 
G8905 Cardiovascular prevention mg I intend to report the cardiovascular prevention measures group 
G8906 Cataract measures group I intend to report the cataract measures group 
G8907 Pt doc no events on discharg Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility 
G8908 Pt doc w burn prior to d/c Patient documented to have received a burn prior to discharge 
G8909 Pt doc no burn prior to d/c Patient documented not to have received a burn prior to discharge 
G8910 Pt doc to have fall in asc Patient documented to have experienced a fall within asc 
G8911 Pt doc no fall in asc Patient documented not to have experienced a fall within ambulatory surgical center 
G8912 Pt doc with wrong event Patient documented to have experienced a wrong site wrong side wrong patient wrong procedure or wrong implant event 
G8913 Pt doc no wrong event Patient documented not to have experienced a wrong site wrong side wrong patient wrong procedure or wrong implant event 
G8914 Pt trans to hosp post d/c Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc 
G8915 Pt not trans to hosp at d/c Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc 
G8916 Pt w iv ab given on time Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis antibiotic initiated on time 
G8917 Pt w iv ab not given on time Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis antibiotic not initiated on time 
G8918 Pt w/o preop order iv ab pro Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis 
G8923 Lvef < 40% or lvsd Left ventricular ejection fraction (lvef) < 40% or documentation of moderately or severely depressed left ventricular systolic function 
G8924 Spir fev1/fvc<70%fev<60% Spirometry test results demonstrate fev1/fvc < 70% fev < 60% predicted and patient has copd symptoms (e.g. dyspnea cough/sputum wheezing) 
G8925 Spir fev1/fvc>=60% & no copd Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70% predicted or patient does not have copd symptoms 
G8926 Spiro no perf or doc Spirometry test not performed or documented reason not given 
G8927 Adj chem pres ajcc iii Adjuvant chemotherapy referred prescribed or previously received for ajcc stage iii colon cancer 
G8928 Adj chem not pres rsn spec Adjuvant chemotherapy not prescribed or previously received for documented reasons (e.g. medical co-morbidities diagnosis date more than 5 years prior to the current visit date patient's diagnosis date is within 120 days of the end of the 12 month reporting period patient's cancer has metastasized medical contraindication/allergy poor performance status other medical reasons patient refusal other patient reasons patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy other system reasons) 
G8929 Adj cmo not pres rsn not gvn Adjuvant chemotherapy not prescribed or previously received reason not given 
G8930 Assess of dep @ initial eval Assessment of depression severity at the initial evaluation 
G8931 Asses of dep not documented Assessment of depression severity not documented reason not given 
G8932 Suicd rsk assessed init eval Suicide risk assessed at the initial evaluation 
G8933 Suicide risk not assessed Suicide risk not assessed at the initial evaluation reason not given 
G8934 Lvef <40% or dep lv sys fcn Left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function 
G8935 Rx ace or arb therapy Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy 
G8936 Pt not eligible ace/arb Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg allergy intolerance pregnancy renal failure due to ace inhibitor diseases of the aortic or mitral valve other medical reasons) or (eg patient declined other patient reasons) or (eg lack of drug availability other reasons attributable to the health care system) 
G8937 No rx ace/arb therapy Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy reason not given 
G8938 Bmi doc onl fup nt doc Bmi is documented as being outside of normal limits follow-up plan is not documented documentation the patient is not eligible 
G8939 Pain as doc positive no f/u Pain assessment documented as positive follow-up plan not documented documentation the patient is not eligible at the time of the encounter 
G8940 Scr dep pos no plan done Screening for depression documented as positive a follow-up plan not completed documented reason 
G8941 Eld maltreatment doc as pos Elder maltreatment screen documented as positive follow-up plan not documented documentation the patient is not eligible for follow-up plan at the time of the encounter 
G8942 Doc fcn/care plan w/30 days Functional outcomes assessment using a standardized tool is documented within the previous 30 days and care plan based on identified deficiencies on the date of the functional outcome assessment is documented 
G8943 Ldlc not pres w/i 12 mo prir Ldl-c result not present or not within 12 months prior 
G8944 Ajcc mel cnr stg 0 - iic Ajcc melanoma cancer stage 0 through iic melanoma 
G8946 Mibm but no dx of breast ca Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g. high risk lesion of breast such as atypical ductal hyperplasia lobular neoplasia atypical lobular hyperplasia lobular carcinoma in situ atypical columnar hyperplasia flat epithelial atypia radial scar complex sclerosing lesion papillary lesion or any lesion with spindle cells) 
G8947 1 or more neuropsych One or more neuropsychiatric symptoms 
G8948 No neuropsych symptoms No neuropsychiatric symptoms 
G8949 Doc pt reas on counsel diet Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g. patient is not willing to discuss diet or exercise interventions to help control blood pressure or the patient said he/she refused to make these changes) 
G8950 Pre-htn or htn doc f/u indc Pre-hypertensive or hypertensive blood pressure reading documented and the indicated follow-up is documented 
G8951 Pre-htn/htn doc no pt f/u Pre-hypertensive or hypertensive blood pressure reading documented indicated follow-up not documented documentation the patient is not eligible 
G8952 Pre-htn/htn no f/u not gvn Pre-hypertensive or hypertensive blood pressure reading documented indicated follow-up not documented reason not given 
G8953 Oncology mg qual act perform All quality actions for the applicable measures in the oncology measures group have been performed for this patient 
G8955 Most recent assess vol mgmt Most recent assessment of adequacy of volume management documented 
G8956 Pt rcv hedia outpt dyls fac Patient receiving maintenance hemodialysis in an outpatient dialysis facility 
G8957 Pt no hedia in outpt fac Patient not receiving maintenance hemodialysis in an outpatient dialysis facility 
G8958 Assess vol mgmt not doc Assessment of adequacy of volume management not documented reason not given 
G8959 Clin tx mdd comm to tx clin Clinician treating major depressive disorder communicates to clinician treating comorbid condition 
G8960 Clin tx mdd not comm Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition reason not given 
G8961 Csit lowrisk surg pts preop Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery 
G8962 Csit on pt any reas 30 days Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery 
G8963 Csi per asx pt w/pci 2 yrs Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years 
G8964 Csi any other than pci 2 yr Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g. symptomatic patient patient greater than 2 years since pci initial evaluation etc) 
G8965 Csit perf on low chd rsk Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment 
G8966 Csit perf sx or high chd rsk Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment 
G8967 Warf or other fda drug presc Warfarin or another fda approved oral anticoagulant is prescribed 
G8968 Doc med not presb Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulant (e.g. atrial appendage device in place) 
G8969 Doc pt rsn no presc warf/fda Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g. patient choice of having atrial appendage device placed) 
G8970 No rsk fac or 1 mod risk te No risk factors or one moderate risk factor for thromboembolism 
G8971 Warfrn or othr antcog no rx Warfarin or another oral anticoagulant that is fda approved not prescribed reason not given 
G8972 1>=risk or>= mod risk for te One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism 
G8973 Mst rcnt hbb < 10g/dl Most recent hemoglobin (hgb) level < 10 g/dl 
G8974 Hgb not doc rns not gvn Hemoglobin level measurement not documented reason not given 
G8975 Hgb <10g/dl med rsn Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g. patients who have non-renal etiologies of anemia [e.g. sickle cell anemia or other hemoglobinopathies hypersplenism primary bone marrow disease anemia related to chemotherapy for diagnosis of malignancy postoperative bleeding active bloodstream or peritoneal infection] other medical reasons) 
G8976 Hgb >= 10 g/dl Most recent hemoglobin (hgb) level >= 10 g/dl 
G8977 Oncology measures grp I intend to report the oncology measures group 
G8978 Mobility current status Mobility: walking & moving around functional limitation current status at therapy episode outset and at reporting intervals 
G8979 Mobility goal status Mobility: walking & moving around functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G8980 Mobility d/c status Mobility: walking & moving around functional limitation discharge status at discharge from therapy or to end reporting 
G8981 Body pos current status Changing & maintaining body position functional limitation current status at therapy episode outset and at reporting intervals 
G8982 Body pos goal status Changing & maintaining body position functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G8983 Body pos d/c status Changing & maintaining body position functional limitation discharge status at discharge from therapy or to end reporting 
G8984 Carry current status Carrying moving & handling objects functional limitation current status at therapy episode outset and at reporting intervals 
G8985 Carry goal status Carrying moving and handling objects projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G8986 Carry d/c status Carrying moving & handling objects functional limitation discharge status at discharge from therapy or to end reporting 
G8987 Self care current status Self care functional limitation current status at therapy episode outset and at reporting intervals 
G8988 Self care goal status Self care functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G8989 Self care d/c status Self care functional limitation discharge status at discharge from therapy or to end reporting 
G8990 Other pt/ot current status Other physical or occupational therapy primary functional limitation current status at therapy episode outset and at reporting intervals 
G8991 Other pt/ot goal status Other physical or occupational therapy primary functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G8992 Other pt/ot  d/c status Other physical or occupational therapy primary functional limitation discharge status at discharge from therapy or to end reporting 
G8993 Sub pt/ot current status Other physical or occupational therapy subsequent functional limitation current status at therapy episode outset and at reporting intervals 
G8994 Sub pt/ot goal status Other physical or occupational therapy subsequent functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G8995 Sub pt/ot d/c status Other physical or occupational therapy subsequent functional limitation discharge status at discharge from therapy or to end reporting 
G8996 Swallow current status Swallowing functional limitation current status at therapy episode outset and at reporting intervals 
G8997 Swallow goal status Swallowing functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G8998 Swallow d/c status Swallowing functional limitation discharge status at discharge from therapy or to end reporting 
G8999 Motor speech current status Motor speech functional limitation current status at therapy episode outset and at reporting intervals 
G9001 Mccd initial rate Coordinated care fee initial rate 
G9002 Mccdmaintenance rate Coordinated care fee maintenance rate 
G9003 Mccd risk adj hi initial Coordinated care fee risk adjusted high initial 
G9004 Mccd risk adj lo initial Coordinated care fee risk adjusted low initial 
G9005 Mccd risk adj maintenance Coordinated care fee risk adjusted maintenance 
G9006 Mccd home monitoring Coordinated care fee home monitoring 
G9007 Mccd sch team conf Coordinated care fee scheduled team conference 
G9008 Mccdphys coor-care ovrsght Coordinated care fee physician coordinated care oversight services 
G9009 Mccd risk adj level 3 Coordinated care fee risk adjusted maintenance level 3 
G9010 Mccd risk adj level 4 Coordinated care fee risk adjusted maintenance level 4 
G9011 Mccd risk adj level 5 Coordinated care fee risk adjusted maintenance level 5 
G9012 Other specified case mgmt Other specified case management service not elsewhere classified 
G9013 Esrd demo bundle level i Esrd demo basic bundle level i 
G9014 Esrd demo bundle-level ii Esrd demo expanded bundle including venous access and related services 
G9016 Demo-smoking cessation coun Smoking cessation counseling individual in the absence of or in addition to any other evaluation and management service per session (6-10 minutes) [demo project code only] 
G9017 Amantadine hcl 100mg oral Amantadine hydrochloride oral per 100 mg (for use in a medicare-approved demonstration project) 
G9018 Zanamivirinhalation pwd 10m Zanamivir inhalation powder administered through inhaler per 10 mg (for use in a medicare-approved demonstration project) 
G9019 Oseltamivir phosphate 75mg Oseltamivir phosphate oral per 75 mg (for use in a medicare-approved demonstration project) 
G9020 Rimantadine hcl 100mg oral Rimantadine hydrochloride oral per 100 mg (for use in a medicare-approved demonstration project) 
G9033 Amantadine hcl oral brand Amantadine hydrochloride oral brand per 100 mg (for use in a medicare-approved demonstration project) 
G9034 Zanamivir inh pwdr brand Zanamivir inhalation powder administered through inhaler brand per 10 mg (for use in a medicare-approved demonstration project) 
G9035 Oseltamivir phosp brand Oseltamivir phosphate oral brand per 75 mg (for use in a medicare-approved demonstration project) 
G9036 Rimantadine hcl brand Rimantadine hydrochloride oral brand per 100 mg (for use in a medicare-approved demonstration project) 
G9050 Oncology work-up evaluation Oncology; primary focus of visit; work-up evaluation or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project) 
G9051 Oncology tx decision-mgmt Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged discussion of treatment options supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project) 
G9052 Onc surveillance for disease Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project) 
G9053 Onc expectant management pt Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project) 
G9054 Onc supervision palliative Oncology; primary focus of visit; supervising coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management end-of-life care planning management of palliative therapies (for use in a medicare-approved demonstration project) 
G9055 Onc visit unspecified nos Oncology; primary focus of visit; other unspecified service not otherwise listed (for use in a medicare-approved demonstration project) 
G9056 Onc prac mgmt adheres guide Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project) 
G9057 Onc pract mgmt differs trial Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project) 
G9058 Onc prac mgmt disagree w/gui Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project) 
G9059 Onc prac mgmt pt opt alterna Oncology; practice guidelines; management differs from guidelines because the patient after being offered treatment consistent with guidelines has opted for alternative treatment or management including no treatment (for use in a medicare-approved demonstration project) 
G9060 Onc prac mgmt dif pt comorb Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project) 
G9061 Onc prac cond noadd by guide Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project) 
G9062 Onc prac guide differs nos Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project) 
G9063 Onc dx nsclc stgi no progres Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9064 Onc dx nsclc stg2 no progres Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9065 Onc dx nsclc stg3a no progre Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9066 Onc dx nsclc stg3b-4 metasta Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9067 Onc dx nsclc dx unknown nos Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9068 Onc dx sclc/nsclc limited Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9069 Onc dx sclc/nsclc ext at dx Oncology; disease status; small cell lung cancer limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9070 Onc dx sclc/nsclc ext unknwn Oncology; disease status; small cell lung cancer limited to small cell and combined small cell/non-small; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9071 Onc dx brst stg1-2b hrnopro Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3 n1 m0; and er and/or pr positive; with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9072 Onc dx brst stg1-2 noprogres Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3 n1 m0; and er and pr negative; with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9073 Onc dx brst stg3-hr no pro Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3 n1 m0; and er and/or pr positive; with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9074 Onc dx brst stg3-noprogress Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3 n1 m0; and er and pr negative; with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9075 Onc dx brst metastic/ recur Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9077 Onc dx prostate t1no progres Oncology; disease status; prostate cancer limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9078 Onc dx prostate t2no progres Oncology; disease status; prostate cancer limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9079 Onc dx prostate t3b-t4noprog Oncology; disease status; prostate cancer limited to adenocarcinoma as predominant cell type; t3b-t4 any n; any t n1 at diagnosis with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9080 Onc dx prostate w/rise psa Oncology; disease status; prostate cancer limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project) 
G9083 Onc dx prostate unknwn nos Oncology; disease status; prostate cancer limited to adenocarcinoma; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9084 Onc dx colon t1-3n1-2no pr Oncology; disease status; colon cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease initially established as t1-3 n0 m0 with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9085 Onc dx colon t4 n0 w/o prog Oncology; disease status; colon cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease initially established as t4 n0 m0 with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9086 Onc dx colon t1-4 no dx prog Oncology; disease status; colon cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease initially established as t1-4 n1-2 m0 with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9087 Onc dx colon metas evid dx Oncology; disease status; colon cancer limited to invasive cancer adenocarcinoma as predominant cell type; m1 at diagnosis metastatic locally recurrent or progressive with current clinical radiologic or biochemical evidence of disease (for use in a medicare-approved demonstration project) 
G9088 Onc dx colon metas noevid dx Oncology; disease status; colon cancer limited to invasive cancer adenocarcinoma as predominant cell type; m1 at diagnosis metastatic locally recurrent or progressive without current clinical radiologic or biochemical evidence of disease (for use in a medicare-approved demonstration project) 
G9089 Onc dx colon extent unknown Oncology; disease status; colon cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9090 Onc dx rectal t1-2 no progr Oncology; disease status; rectal cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease initially established as t1-2 n0 m0 (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9091 Onc dx rectal t3 n0 no prog Oncology; disease status; rectal cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease initially established as t3 n0 m0 (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9092 Onc dx rectal t1-3n1-2noprg Oncology; disease status; rectal cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease initially established as t1-3 n1-2 m0 (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9093 Onc dx rectal t4nm0 no prg Oncology; disease status; rectal cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease initially established as t4 any n m0 (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9094 Onc dx rectal m1 w/mets prog Oncology; disease status; rectal cancer limited to invasive cancer adenocarcinoma as predominant cell type; m1 at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9095 Onc dx rectal extent unknwn Oncology; disease status; rectal cancer limited to invasive cancer adenocarcinoma as predominant cell type; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9096 Onc dx esophag t1-t3 noprog Oncology; disease status; esophageal cancer limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3 n0-n1 or nx (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9097 Onc dx esophageal t4 no prog Oncology; disease status; esophageal cancer limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4 any n m0 (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9098 Onc dx esophageal mets recur Oncology; disease status; esophageal cancer limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9099 Onc dx esophageal unknown Oncology; disease status; esophageal cancer limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9100 Onc dx gastric no recurrence Oncology; disease status; gastric cancer limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence progression or metastases (for use in a medicare-approved demonstration project) 
G9101 Onc dx gastric p r1-r2noprog Oncology; disease status; gastric cancer limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression or metastases (for use in a medicare-approved demonstration project) 
G9102 Onc dx gastric unresectable Oncology; disease status; gastric cancer limited to adenocarcinoma as predominant cell type; clinical or pathologic m0 unresectable with no evidence of disease progression or metastases (for use in a medicare-approved demonstration project) 
G9103 Onc dx gastric recurrent Oncology; disease status; gastric cancer limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9104 Onc dx gastric unknown nos Oncology; disease status; gastric cancer limited to adenocarcinoma as predominant cell type; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9105 Onc dx pancreatc p r0 res no Oncology; disease status; pancreatic cancer limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9106 Onc dx pancreatc p r1/r2 no Oncology; disease status; pancreatic cancer limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression or metastases (for use in a medicare-approved demonstration project) 
G9107 Onc dx pancreatic unresectab Oncology; disease status; pancreatic cancer limited to adenocarcinoma; unresectable at diagnosis m1 at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9108 Onc dx pancreatic unknwn nos Oncology; disease status; pancreatic cancer limited to adenocarcinoma; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9109 Onc dx head/neck t1-t2no prg Oncology; disease status; head and neck cancer limited to cancers of oral cavity pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0 m0 (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9110 Onc dx head/neck t3-4 noprog Oncology; disease status; head and neck cancer limited to cancers of oral cavity pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3 m0 (prior to neo-adjuvant therapy if any) with no evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9111 Onc dx head/neck m1 mets rec Oncology; disease status; head and neck cancer limited to cancers of oral cavity pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis metastatic locally recurrent or progressive (for use in a medicare-approved demonstration project) 
G9112 Onc dx head/neck ext unknown Oncology; disease status; head and neck cancer limited to cancers of oral cavity pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9113 Onc dx ovarian stg1a-b no pr Oncology; disease status; ovarian cancer limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9114 Onc dx ovarian stg1a-b or 2 Oncology; disease status; ovarian cancer limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9115 Onc dx ovarian stg3/4 noprog Oncology; disease status; ovarian cancer limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression recurrence or metastases (for use in a medicare-approved demonstration project) 
G9116 Onc dx ovarian recurrence Oncology; disease status; ovarian cancer limited to epithelial cancer; evidence of disease progression or recurrence and/or platinum resistance (for use in a medicare-approved demonstration project) 
G9117 Onc dx ovarian unknown nos Oncology; disease status; ovarian cancer limited to epithelial cancer; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9123 Onc dx cml chronic phase Oncology; disease status; chronic myelogenous leukemia limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic cytogenetic or molecular remission (for use in a medicare-approved demonstration project) 
G9124 Onc dx cml acceler phase Oncology; disease status; chronic myelogenous leukemia limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic or molecular remission (for use in a medicare-approved demonstration project) 
G9125 Onc dx cml blast phase Oncology; disease status; chronic myelogenous leukemia limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic cytogenetic or molecular remission (for use in a medicare-approved demonstration project) 
G9126 Onc dx cml remission Oncology; disease status; chronic myelogenous leukemia limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic cytogenetic or molecular remission (for use in a medicare-approved demonstration project) 
G9128 Onc dx multi myeloma stage i Oncology; disease status; limited to multiple myeloma systemic disease; smoldering stage i (for use in a medicare-approved demonstration project) 
G9129 Onc dx mult myeloma stg2 hig Oncology; disease status; limited to multiple myeloma systemic disease; stage ii or higher (for use in a medicare-approved demonstration project) 
G9130 Onc dx multi myeloma unknown Oncology; disease status; limited to multiple myeloma systemic disease; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9131 Onc dx brst unknown nos Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown staging in progress or not listed (for use in a medicare-approved demonstration project) 
G9132 Onc dx prostate mets no cast Oncology; disease status; prostate cancer limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g. rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project) 
G9133 Onc dx prostate clinical met Oncology; disease status; prostate cancer limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project) 
G9134 Onc nhlstg 1-2 no relap no Oncology; disease status; non-hodgkin's lymphoma any cellular classification; stage i ii at diagnosis not relapsed not refractory (for use in a medicare-approved demonstration project) 
G9135 Onc dx nhl stg 3-4 not relap Oncology; disease status; non-hodgkin's lymphoma any cellular classification; stage iii iv not relapsed not refractory (for use in a medicare-approved demonstration project) 
G9136 Onc dx nhl trans to lg bcell Oncology; disease status; non-hodgkin's lymphoma transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project) 
G9137 Onc dx nhl relapse/refractor Oncology; disease status; non-hodgkin's lymphoma any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project) 
G9138 Onc dx nhl stg unknown Oncology; disease status; non-hodgkin's lymphoma any cellular classification; diagnostic evaluation stage not determined evaluation of possible relapse or non-response to therapy or not listed (for use in a medicare-approved demonstration project) 
G9139 Onc dx cml dx status unknown Oncology; disease status; chronic myelogenous leukemia limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown staging in progress not listed (for use in a medicare-approved demonstration project) 
G9140 Frontier extended stay demo Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours after the first 4 hours 
G9143 Warfarin respon genetic test Warfarin responsiveness testing by genetic technique using any method any number of specimen(s) 
G9147 Outpt iv insulin tx any mea Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous by any means guided by the results of measurements for: respiratory quotient; and/or urine urea nitrogen (uun); and/or arterial venous or capillary glucose; and/or potassium concentration 
G9148 Medical home level 1 National committee for quality assurance - level 1 medical home 
G9149 Medical home level ii National committee for quality assurance - level 2 medical home 
G9150 Medical home level iii National committee for quality assurance - level 3 medical home 
G9151 Mapcp demo state Mapcp demonstration - state provided services 
G9152 Mapcp demo community Mapcp demonstration - community health teams 
G9153 Mapcp demo physician Mapcp demonstration - physician incentive pool 
G9156 Evaluation for wheelchair Evaluation for wheelchair requiring face to face visit with physician 
G9157 Transesoph doppl cardiac mon Transesophageal doppler measurement of cardiac output (including probe placement image acquisition and interpretation per course of treatment) for monitoring purposes 
G9158 Motor speech d/c status Motor speech functional limitation discharge status at discharge from therapy or to end reporting 
G9159 Lang comp current status Spoken language comprehension functional limitation current status at therapy episode outset and at reporting intervals 
G9160 Lang comp goal status Spoken language comprehension functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G9161 Lang comp d/c status Spoken language comprehension functional limitation discharge status at discharge from therapy or to end reporting 
G9162 Lang express current status Spoken language expression functional limitation current status at therapy episode outset and at reporting intervals 
G9163 Lang express goal status Spoken language expression functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G9164 Lang express d/c status Spoken language expression functional limitation discharge status at discharge from therapy or to end reporting 
G9165 Atten current status Attention functional limitation current status at therapy episode outset and at reporting intervals 
G9166 Atten goal status Attention functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G9167 Atten d/c status Attention functional limitation discharge status at discharge from therapy or to end reporting 
G9168 Memory current status Memory functional limitation current status at therapy episode outset and at reporting intervals 
G9169 Memory goal status Memory functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G9170 Memory d/c status Memory functional limitation discharge status at discharge from therapy or to end reporting 
G9171 Voice current status Voice functional limitation current status at therapy episode outset and at reporting intervals 
G9172 Voice goal status Voice functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G9173 Voice d/c status Voice functional limitation discharge status at discharge from therapy or to end reporting 
G9174 Speech lang current status Other speech language pathology functional limitation current status at therapy episode outset and at reporting intervals 
G9175 Speech lang goal status Other speech language pathology functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G9176 Speech lang d/c status Other speech language pathology functional limitation discharge status at discharge from therapy or to end reporting 
G9186 Motor speech goal status Motor speech functional limitation projected goal status at therapy episode outset at reporting intervals and at discharge or to end reporting 
G9187 Bpci home visit Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including but not limited to assessment of safety falls clinical status fluid status medication reconciliation/management patient compliance with orders/plan of care performance of activities of daily living appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code 
G9188 Beta not given no reason Beta-blocker therapy not prescribed reason not given 
G9189 Beta pres or already taking Beta-blocker therapy prescribed or currently being taken 
G9190 Medical reason for no beta Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg allergy intolerance other medical reasons) 
G9191 Pt reason for no beta Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg patient declined other patient reasons) 
G9192 System reason for no beta Documentation of system reason(s) for not prescribing beta-blocker therapy (eg other reasons attributable to the health care system) 
G9193 Doc not eligible for dep med Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression 
G9194 Mdd pt treated for 180d Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase 
G9195 Mdd pt not treated for 180d Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase 
G9196 Med reason for no ceph Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g. patients enrolled in clinical trials patients with documented infection prior to surgical procedure of interest patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics] patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics] other medical reason(s)) 
G9197 Order for ceph Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis 
G9198 No order for ceph no reason Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented reason not given 
G9199 Doc reason for no vte Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg patient is ambulatory patient expired during inpatient stay patient already on warfarin or another anticoagulant other medical reason(s) or eg patient left against medical advice other patient reason(s)) 
G9200 No reason for no vte Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission reason not given 
G9201 Vte given upon admission Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission 
G9202 Hep c aby pos Patients with a positive hepatitis c antibody test 
G9203 Hep c rna done prior to med Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c 
G9204 No reason for no hep c rna Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c reason not given 
G9205 Hep c antiviral started Patient starting antiviral treatmentfor hepatitis c during the measurement period 
G9206 Hep c therapy started Patient starting antiviral treatment for hepatitis c during the measurement period 
G9207 Hep c genotype prior to med Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c 
G9208 No reason for no hep c geno Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c reason not given 
G9209 Hep c rna 4to12 wk after med Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment 
G9210 No hepc rna after med docrsn Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g. patients whose treatment was discontinued during the testing period prior to testing other medical reasons patient declined other patient reasons) 
G9211 No hepc rna after med no rsn Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment reason not given 
G9212 Doc of dsm-iv init eval Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation 
G9213 No doc of dsm-iv Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation reason not otherwise specified 
G9214 Cd4 count documented Cd4+ cell count or cd4+ cell percentage results documented 
G9215 No cd4 count no reason Cd4+ cell count or percentage not documented as performed reason not given 
G9216 No pcp proph at dx no reason Pcp prophylaxis was not prescribed at time of diagnosis of hiv reason not given 
G9217 No pcp proph low cd4 norsn Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 reason not given 
G9218 No pcp prop low at cd4 norsn Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% reason not given 
G9219 No oder pjp for med reason Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e. patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis) 
G9220 No order for pjp for medrsn Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e. patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis) 
G9221 Pjp proph prescribed Pneumocystis jiroveci pneumonia prophlaxis prescribed 
G9222 Pjp proph ordered low cd4 Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3 
G9223 Pjp proph ordered cd4 low Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% 
G9224 Medrsn no foot exam Documentation of medical reason for not performing foot exam (e.g. patient with bilateral foot/leg amputation) 
G9225 Norsn no foot exam Foot exam was not performed reason not given 
G9226 3 comp foot exam completed Foot examination performed (includes examination through visual inspection sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork pinprick sensation ankle reflexes or vibration perception threshold and pulse exam; report when all of the 3 components are completed) 
G9227 Foa doc care plan not doc Functional outcome assessment documented care plan not documented documentation the patient is not eligible for a care plan at the time of the encounter 
G9228 Gc chl syp documented Chlamydia gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings) 
G9229 Ptrsn no gc chl syp test Chlamydia gonorrhea and syphilis screening results not documented (patient refusal is the only allowed exception) 
G9230 Norsn for gc chl syp test Chlamydia gonorrhea and syphilis not screened reason not given 
G9231 Doc esrd dia trans preg Documentation of end stage renal disease (esrd) dialysis renal transplant before or during the measurement period or pregnancy during the measurement period 
G9232 Ptrsn no comm comorbid Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g. patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition or any other specified patient reason) 
G9233 Tkr composite All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient 
G9234 Tkr intent I intend to report the total knee replacement measures group 
G9235 Gs mg composite All quality actions for the applicable measures in the general surgery measures group have been performed for this patient 
G9236 Op rad mg composite All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient 
G9237 Gs mg intent I intend to report the general surgery measures group 
G9238 Op rad mg intent I intend to report the optimizing patient exposure to ionizing radiation measures group 
G9239 Doc rsn hemod & cath acc Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g. patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg) time-limited trial of hemodialysis other medical reasons patient declined avf/avg other patient reasons patient followed by reporting nephrologist for fewer than 90 days other system reasons) 
G9240 Doc pt w cath maint dia Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated 
G9241 Doc pt w out cath maint dia Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated 
G9242 Doc viral load >=200 Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed 
G9243 Doc viral load <200 Documentation of viral load less than 200 copies/ml 
G9244 Antiviral not ordered Antiretroviral thereapy not prescribed 
G9245 Antiviral ordered Antiretroviral therapy prescribed 
G9246 No med visit in 24mo Patient did not have at least one medical visit in each 6 month period of the 24 month measurement period with a minimum of 60 days between medical visits 
G9247 1 med visit in 24mo Patient had at least one medical visit in each 6 month period of the 24 month measurement period with a minimum of 60 days between medical visits 
G9248 No med visit 6mo Patient did not have a medical visit in the last 6 months 
G9249 Med visit w in 6mo Patient had a medical visit in the last 6 months 
G9250 Doc of pain comfort 48hr Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment 
G9251 Doc no pain comfort 48hr Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment 
G9252 Neo detect scrn colo Adenoma(s) or other neoplasm detected during screening colonoscopy 
G9253 No neo detect scrn colo Adenoma(s) or other neoplasm not detected during screening colonoscopy 
G9254 Doc pt dischg >2d Documentation of patient discharged to home later than post-operative day 2 following cas 
G9255 Doc pt dischg <=2d Documentation of patient discharged to home no later than post operative day 2 following cas 
G9256 Doc of pat death after cas Documentation of patient death following cas 
G9257 Doc of pat stroke after cas Documentation of patient stroke following cas 
G9258 Doc of pat stroke after cea Documentation of patient stroke following cea 
G9259 Survive/no stroke post cas Documentation of patient survival and absence of stroke following cas 
G9260 Doc of pat death after cea Documentation of patient death following cea 
G9261 Survive/no stroke post cea Documentation of patient survival and absence of stroke following cea 
G9262 Doc of death post-aaa repair Documentation of patient death in the hospital following endovascular aaa repair 
G9263 Doc of disch post-aaa repair Documentation of patient discharged alive following endovascular aaa repair 
G9264 Doc rsn hemod w/cath >=90d Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g. other medical reasons patient declined arteriovenous fistula (avf)/arteriovenous graft (avg) other patient reasons) 
G9265 Doc cath >90d for maint dia Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access 
G9266 Norsn pt cath >=90d Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access 
G9267 Doc comp or mort w in 30d Documentation of patient with one or more complications or mortality within 30 days 
G9268 Doc comp or mort w in 90d Documentation of patient with one or more complications within 90 days 
G9269 Doc no comp or mort w in 30d Documentation of patient without one or more complications and without mortality within 30 days 
G9270 Doc no comp or mort w in 90d Documentation of patient without one or more complications within 90 days 
G9271 Ldl under 100 Ldl value < 100 
G9272 Ldl 100 and over Ldl value >= 100 
G9273 Sys<140 and dia<90 Blood pressure has a systolic value of < 140 and a diastolic value of < 90 
G9274 Bp out of nrml limits Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90 
G9275 Doc of non tobacco user Documentation that patient is a current non-tobacco user 
G9276 Doc of tobacco user Documentation that patient is a current tobacco user 
G9277 Doc daily aspirin or contra Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use allergy to aspirin or anti-platelets history of gastrointestinal bleed and bleeding disorder; additionally the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents documented risk for drug interaction uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux) 
G9278 Doc no daily aspirin Documentation that the patient is not on daily aspirin or anti-platelet regimen 
G9279 Pne scrn done doc vac done Pneumococcal screening performed and documentation of vaccination received prior to discharge 
G9280 Pne not given norsn Pneumococcal vaccination not administered prior to discharge reason not specified 
G9281 Pne scrn done doc not ind Screening performed and documentation that vaccination not indicated/patient refusal 
G9282 Doc medrsn no histo type Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g. biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons) 
G9283 Hist type doc on report Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation 
G9284 No hist type doc on report Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation 
G9285 Site not small cell lung ca Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer 
G9286 Antibio rx w in 10d of sympt Antibiotic regimen prescribed within 10 days after onset of symptoms 
G9287 No antibio w in 10d of sympt Antibiotic regimen not prescribed within 10 days after onset of symptoms 
G9288 Doc medrsn no hist type rpt Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g. a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons) 
G9289 Doc type nsm lung ca Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation 
G9290 No doc type nsm lung ca Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation 
G9291 Not nsm lung ca Specimen site other than anatomic location of lung is not classified as non small cell lung cancer or classified as nsclc-nos 
G9292 Medrsn no pt category Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1 mitotic rate (e.g. negative skin biopsies in a patient with a history of melanoma or other documented medical reasons) 
G9293 No pt category on report Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1 mitotic rate 
G9294 Pt cat and thck on report Pathology report includes the pt category and a statement on thickness and ulceration and for pt1 mitotic rate 
G9295 Non cutaneous loc Specimen site other than anatomic cutaneous location 
G9296 Doc share dec prior proc Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g. nsaids analgesics weight loss exercise injections) prior to the procedure 
G9297 No doc share dec prior proc Shared decision-making including discussion of conservative (non-surgical) therapy (e.g. nsaids analgesics weight loss exercise injections) prior to the procedure not documented reason not given 
G9298 Eval risk vte card 30d prior Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt pe mi arrhythmia and stroke) 
G9299 No eval riskk vte card prior Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g. history of dvt pe mi arrhythmia and stroke reason not given) 
G9300 Doc medrsn no compl antibio Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g. a tourniquet was not used) 
G9301 Doc compl inf antibio Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet 
G9302 Norsn incomp inf antibio Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet reason not given 
G9303 Norsn no pros info op rpt Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer the brand name of the prosthetic implant and the size of each prosthetic implant reason not given 
G9304 Pros info op rpt Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer the brand name of the prosthetic implant and the size of each prosthetic implant 
G9305 No interv req for leak Intervention for presence of leak of endoluminal contents through an anastomosis not required 
G9306 Interv req for leak Intervention for presence of leak of endoluminal contents through an anastomosis required 
G9307 No ret for surg w in 30d No return to the operating room for a surgical procedure for complications of the principal operative procedure within 30 days of the principal operative procedure 
G9308 Unpl ret or w/compl w/in 30d Unplanned return to the operating room for a surgical procedure for complications of the principal operative procedure within 30 days of the principal operative procedure 
G9309 No unplnd hosp readm in 30d No unplanned hospital readmission within 30 days of principal procedure 
G9310 Unplnd hosp readm in 30d Unplanned hospital readmission within 30 days of principal procedure 
G9311 No surg site infection No surgical site infection 
G9312 Surgical site infection Surgical site infection 
G9313 Amoxic not presc as 1st line Amoxicillin with or without clavulanate not prescribed as first line antibiotic at the time of diagnosis for documented reason 
G9314 Norsn not first line amox Amoxicillin with or without clavulanate not prescribed as first line antibiotic at the time of diagnosis reason not given 
G9315 Doc first line amox Documentation amoxicillin with or without clavulanate prescribed as a first line antibiotic at the time of diagnosis 
G9316 Doc comm risk calc Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data the specific risk calculator used and communication of risk assessment from risk calculator with the patient or family 
G9317 No doc comm risk calc Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data the specific risk calculator used and communication of risk assessment from risk calculator with the patient or family not completed 
G9318 Image std nomenclature Imaging study named according to standardized nomenclature 
G9319 Image not std nomenclature Imaging study not named according to standardized nomenclature reason not given 
G9320 Medrsn no std nomenclature Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) 
G9321 Doc count of ct in 12mo Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study 
G9322 No doc count of ct in 12mo Count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study reason not given 
G9323 Mdrsn no doc cnt of ct Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) 
G9324 Not all data norsn All necessary data elements not included reason not given 
G9325 Medrsn no ct rpt to reg Ct studies not reported to a radiation dose index registry due to medical reasons (eg ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) 
G9326 Ct done no rad ds index nrg Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements reason not given 
G9327 Ct done rad ds index Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements 
G9328 Medrsn no dicom format doc Dicom format image data availability not documented in final report due to medical reasons (eg ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) 
G9329 Norsn no dicom format doc Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure media free reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report reason not given 
G9340 Dicom format doc on rpt Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure media free reciprocally searchable basis with patient authorization for at least a 12-month period after the study 
G9341 Srch for ct w in 12 mos Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure authorized media-free shared archive prior to an imaging study being performed 
G9342 No srch for ct in 12mo norsn Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure authorized media-free shared archive reason not given 
G9343 Medrsn no dicom srch Due to medical reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure authorized media-free shared archive (e.g. ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) 
G9344 Sysrsn no dicom srch Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure authorized media-free shared archive (e.g. non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system) 
G9345 Follow up pulm nod Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g. follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors 
G9346 No follow up pulm nod Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g. patients with known malignant disease patients with unexplained fever ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) 
G9347 No follow up pulm nod norsn Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules reason not given 
G9348 Doc rsn for ord ct scan Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons 
G9349 Ct within 28 days Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis 
G9350 No doc sinus ct 28d or dx Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis 
G9351 Doc >1 sinus ct w 90d dx More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis 
G9352 Not >1 sinus ct w 90d dx More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis reason not given 
G9353 Medrsn >1 sinus ct w 90d dx More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg patients with complications second ct obtained prior to surgery other medical reasons) 
G9354 1 or no ct sinus w/in 90d dx One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis 
G9355 No early ind/delivery Early elective delivery or early induction not performed (less than 39 weeks gestation) 
G9356 Early ind/delivery Early elective delivery or early induction performed (less than 39 week gestation) 
G9357 Pp eval/edu perf Post-partum screenings evaluations and education performed 
G9358 Pp eval/edu not perf Post-partum screenings evaluations and education not performed 
G9359 Neg mgd pos tb notact Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to the treatment with a biologic immune response modifier 
G9360 No doc of neg or man pos tb No documentation of negative or managed positive tb screen 
G9361 Doc rsn elect c-sec/induct Medical indication for induction [documentation of reason(s) for elective delivery (c-section) or early induction (e.g. hemorrhage and placental complications hypertension preeclampsia and eclampsia rupture of membranes-premature or prolonged maternal conditions complicating pregnancy/delivery fetal conditions complicating pregnancy/delivery late pregnancy prior uterine surgery or participation in clinical trial)] 
G9362 Mac or pnb w/o genanes >60m Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer as documented in the anesthesia record 
G9363 Mac or pnb w/o genanes <60m Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes as documented in the anesthesia record 
G9364 Sinus caus bac inx Sinusitis caused by or presumed to be caused by bacterial infection 
G9365 1high risk med ord One high-risk medication ordered 
G9366 1high risk no ord One high-risk medication not ordered 
G9367 >= 2 same hi-rsk med ord At least two orders for the same high-risk medication 
G9368 >= 2 same hi-rsk med not ord At least two orders for the same high-risk medications not ordered 
G9369 Fill 2 rx antipsych Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater 
G9370 Not fill 2 rx antipsych Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater 
G9376 Contd ret attach at 6mth f/u Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery 
G9377 No ret attach after 6mt Patient did not have the retina attached after 6 months following only one surgery 
G9378 Contd ret attach f/u vis Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) 
G9379 No acheive flat ret 6mth Patient did not achieve flat retinas six months post surgery 
G9380 Off assis eol iss Patient offered assistance with end of life issues during the measurement period 
G9381 Doc med reas no offer eol Documentation of medical reason(s) for not offering assistance with end of life issues (e.g. patient in hospice care patient in terminal phase) during the measurement period 
G9382 No off assis eol Patient not offered assistance with end of life issues during the measurement period 
G9383 Recd scrn hcv infec Patient received screening for hcv infection within the 12 month reporting period 
G9384 Doc med rsn no hcv scrn Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g. decompensated cirrhosis indicating advanced disease [i.e. ascites esophageal variceal bleeding hepatic encephalopathy] hepatocellular carcinoma waitlist for organ transplant limited life expectancy other medical reasons) 
G9385 Doc pt reas not rec hcv srn Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g. patient declined other patient reasons) 
G9386 Scrn hcv infec not recd Screening for hcv infection not received within the 12 month reporting period reason not given 
G9389 Unpln rup post cap Unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery 
G9390 No unpln rup post cap No unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery 
G9391 Achv refrac +1d Patient achieves refraction +-1 d for the eye that underwent cataract surgery measured at the one month follow up visit 
G9392 Not achv refrac +1d Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery measured at the one month follow up visit 
G9393 Ini phq9 >9 remiss <5 Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five 
G9394 Dx bipol death nhres hosp Patient who had a diagnosis of bipolar disorder or personality disorder death permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period 
G9395 Ini phq9 >9 no remiss >=5 Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five 
G9396 Ini phq9 >9 not assess Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days) 
G9399 Doc disc tx choices Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype risks and benefits evidence of effectiveness and patient preferences toward the outcome of the treatment 
G9400 Doc reas no disc tx opt Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons 
G9401 No disc tx choices No documentation of a discussion in the patient record of a discussion between the physician or other qualfied healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype risks and benefits evidence of effectiveness and patient preferences toward treatment 
G9402 Recd f/u w/in 30d disch Patient received follow-up on the date of discharge or within 30 days after discharge 
G9403 Doc reas no 30 day f/u Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g. patient death prior to follow-up visit patient non-compliant for visit follow-up) 
G9404 No 30 day f/u Patient did not receive follow-up on the date of discharge or within 30 days after discharge 
G9405 Recd f/u w/in 7d dc Patient received follow-up within 7 days after discharge 
G9406 Doc reas no 7d f/u Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit patient non-compliance for visit follow-up) 
G9407 No 7d f/u Patient did not receive follow-up on or within 7 days after discharge 
G9408 Card tamp w/in 30d Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days 
G9409 No card tamp e/in 30d Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days 
G9410 Admit w/in 180d req remov Patient admitted within 180 days status post cied implantation replacement or revision with an infection requiring device removal or surgical revision 
G9411 No admit w/in 180d req remov Patient not admitted within 180 days status post cied implantation replacement or revision with an infection requiring device removal or surgical revision 
G9412 Admit w/in 180d req surg rev Patient admitted within 180 days status post cied implantation replacement or revision with an infection requiring device removal or surgical revision 
G9413 No admit req surg rev Patient not admitted within 180 days status post cied implantation replacement or revision with an infection requiring device removal or surgical revision 
G9414 1dose menig vac btwn 11 & 13 Patient had one dose of meningococcal vaccine (serogroups a c w y) on or between the patient's 11th and 13th birthdays 
G9415 No 1dose meni vac btwn 11&13 Patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays 
G9416 Pt 1 tdap betw 10-13 yrs Patient had one tetanus diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays 
G9417 Pt not 1 tdap betw 10-13 yrs Patient did not have one tetanus diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays 
G9418 Lungcx bx rpt docs class Primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation 
G9419 Med reas not incl histo type Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. biopsy taken for other purposes in a patient with a history of primary non-small cell lung cancer or other documented medical reasons) 
G9420 Spec site no lung Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer 
G9421 Lung cx bx rpt no doc class Primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation 
G9422 Rpt doc class histo type Primary lung carcinoma resection report documents pt category pn category and for non-small cell lung cancer histologic type (squamous cell carcinoma adenocarcinoma and not nsclc-nos) 
G9423 Med reas rpt no histo type Documentation of medical reason for not including pt category pn category and histologic type [for patient with appropriate exclusion criteria (e.g. metastatic disease benign tumors malignant tumors other than carcinomas inadequate surgical specimens)] 
G9424 Site no lung or lung cx Specimen site other than anatomic location of lung or classified as nsclc-nos 
G9425 Spec rpt no doc class histo Primary lung carcinoma resection report does not document pt category pn category and for non-small cell lung cancer histologic type (squamous cell carcinoma adenocarcinoma) 
G9426 Impr med time edarr pain med Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients 
G9427 No impro med time pain med Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients 
G9428 Patho rpt incl pt ctg Pathology report includes the pt category and a statement on thickness ulceration and mitotic rate 
G9429 Doc med rsn no pt cat Documentation of medical reason(s) for not including pt category and a statement on thickness  ulceration and mitotic rate (e.g. negative skin biopsies in a patient with a history of melanoma or other documented medical reasons) 
G9430 Spec site no cutaneous Specimen site other than anatomic cutaneous location 
G9431 Patho rpt no pt ctg Pathology report does not include the pt category and a statement on thickness ulceration and mitotic rate 
G9432 Asth controlled Asthma well-controlled based on the act c-act acq or ataq score and results documented 
G9433 Death nhres hospice Death permanent nursing home resident or receiving hospice or palliative care any time during the measurement period 
G9434 Asth not controlled Asthma not well-controlled based on the act c-act acq or ataq score or specified asthma control tool not used reason not given 
G9435 Asp presc disch Aspirin prescribed at discharge 
G9436 Asp not presc doc reas Aspirin not prescribed for documented reasons (e.g. allergy medical intolerance history of bleed) 
G9437 Asp not presc disch Aspirin not prescribed at discharge 
G9438 P2y inhib presc P2y inhibitor prescribed at discharge 
G9439 P2y inhib not presc doc reas P2y inhibitor not prescribed for documented reasons (e.g. allergy medical intolerance history of bleed) 
G9440 P2y inhib not presc P2y inhibitor not prescribed at discharge 
G9441 Statin presc disch Statin prescribed at discharge 
G9442 Statin not presc doc reas Statin not prescribed for documented reasons (e.g. allergy medical intolerance) 
G9443 Statin not presc disch Statin not prescribed at discharge 
G9448 Born 1945-1965 Patients who were born in the years 1945?1965 
G9449 Hx bld transf b/f 1992 History of receiving blood transfusions prior to 1992 
G9450 Hx injec drug use History of injection drug use 
G9451 1x scrn hcv infect Patient received one-time screening for hcv infection 
G9452 Doc med reas no scrn hcv Documentation of medical reason(s) for not receiving one-time screening for hcv infection (e.g. decompensated cirrhosis indicating advanced disease [ie ascites esophageal variceal bleeding hepatic encephalopathy] hepatocellular carcinoma waitlist for organ transplant limited life expectancy other medical reasons) 
G9453 Pt reas no hcv infect Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g. patient declined other patient reasons) 
G9454 No scr hcv inf 12 mth rp One-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection reason not given 
G9455 Abd imag w/us ct or mri Patient underwent abdominal imaging with ultrasound contrast enhanced ct or contrast mri for hcc 
G9456 Doc med pt reas no hcc scrn Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years hepatic decompensation and not a candidate for liver transplantation or other medical reasons; patient reasons: patient declined or other patient reasons (e.g. cost of tests time related to accessing testing equipment) 
G9457 Pt no abd img no doc rsn Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period 
G9458 Tob user recd cess interv Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use counseling on the benefits of quitting smoking or tobacco use assistance with or referral to external smoking or tobacco cessation support programs or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user 
G9459 Tob non-user Currently a tobacco non-user 
G9460 No tob assess or cess inter Tobacco assessment or tobacco cessation intervention not performed reason not given 
G9463 Sinusitis intent I intend to report the sinusitis measures group 
G9464 Sinusitis comp All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient 
G9465 Aoe intent I intend to report the acute otitis externa (aoe) measures group 
G9466 Aoe comp All quality actions for the applicable measures in the aoe measures group have been performed for this patient 
G9467 Recd cortico >=10mg/day >60d Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve months 
G9468 No recd cortico>=10mg/d >60d Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills 
G9469 Rec cortico>90d or 1rx 900mg Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fills 
G9470 No rec cortico>60d 1rx 600mg Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills 
G9471 W/in 2yr dxa not order Within the past 2 years central dual-energy x-ray absorptiometry (dxa) not ordered or documented 
G9472 No dxa no med hx no rv sx Within the past 2 years central dual-energy x-ray absorptiometry (dxa) not ordered and documented no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed 
G9473 Chap services at hospice Services performed by chaplain in the hospice setting each 15 minutes 
G9474 Diet counsel at hospice Services performed by dietary counselor in the hospice setting each 15 minutes 
G9475 Other counselor at hospice Services performed by other counselor in the hospice setting each 15 minutes 
G9476 Volun service at hospice Services performed by volunteer in the hospice setting each 15 minutes 
G9477 Care coord at hospice Services performed by care coordinator in the hospice setting each 15 minutes 
G9478 Othe therapist at hospice Services performed by other qualified therapist in the hospice setting each 15 minutes 
G9479 Pharmacist at hospice Services performed by qualified pharmacist in the hospice setting each 15 minutes 
G9480 Admission to mccm Admission to medicare care choice model program (mccm) 
G9481 Remote e/m new pt 10mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project which requires these 3 key components: a problem focused history;  a problem focused examination; and straightforward medical decision making furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are self limited or minor.  typically 10 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9482 Remote e/m new pt 20mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination;  straightforward medical decision making furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are of low to moderate severity.  typically 20 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9483 Remote e/m new pt 30mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are of moderate severity.  typically 30 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9484 Remote e/m new pt 45mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are of moderate to high severity.  typically 45 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9485 Remote e/m new pt 60mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are of moderate to high severity.  typically 60 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9486 Remote e/m est. pt 10mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are self limited or minor.  typically 10 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9487 Remote e/m est. pt 15mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are of low to moderate severity.  typically 15 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9488 Remote e/m est. pt 25mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are of moderate to high severity.  typically 25 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9489 Remote e/m est. pt 40mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually the presenting problem(s) are of moderate to high severity.  typically 40 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9490 Cmmi mod home visit Cms innovation center models home visit for patient assessment performed by clinical staff for an individual not considered homebound including but not necessarily limited to patient assessment of clinical status safety/fall prevention functional status/ambulation medication reconciliation/management compliance with orders/plan of care performance of activities of daily living and ensuring beneficiary connections to community and other services.  (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code 
G9496 Doc rsn no adeno/neopl detec Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g. neoplasm detected is only diagnosed as traditional serrated adenoma sessile serrated polyp or sessile serrated adenoma 
G9497 Rec inst no smoke day surg Received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery 
G9498 Abx reg prescribed Antibiotic regimen prescribed 
G9499 No start/rec antvir tx hep c Patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period 
G9500 Rad expos ind/exp tm doc Radiation exposure indices or exposure time and number of fluorographic images in final report for procedures using fluoroscopy documented 
G9501 Rad expos ind/exp tm no doc Radiation exposure indices or exposure time and number of fluorographic images not documented in final report for procedure using fluoroscopy reason not given 
G9502 Med reas no perf foot exam Documentation of medical reason for not performing foot exam (i.e. patients who have had either a bilateral amputation above or below the knee or both a left and right amputation above or below the knee before or during the measurement period) 
G9503 Pt tk tams hcl Patient taking tamsulosin hydrochloride 
G9504 Doc rsn hep b stat not asses Documented reason for not assessing hepatitis b virus (hbv) status (e.g. patient not initiating anti-tnf therapy patient declined) prior to initiating anti-tnf therapy 
G9505 Abx pres w/in 10 dys of symp Antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason 
G9506 Bio imm resp mod presc Biologic immune response modifier prescribed 
G9507 Doc reas on statin or contra Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period active liver disease rhabdomyolysis end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period woman of child-bearing age not actively taking birth control allergy to statin drug interaction (hiv protease inhibitors nefazodone cyclosporine gemfibrozil and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) 
G9508 Doc pt not on statin Documentation that the patient is not on a statin medication 
G9509 Adit mdd dys rem 12 mnths Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5 
G9510 Remis12m not phq-9 score <5 Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve  month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5 
G9511 Idx evt dte phq>9 doc 12 mo Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period 
G9512 Indiv pdc > 0.8 Individual had a pdc of 0.8 or greater 
G9513 Indiv pdc not > 0.8 Individual did not have a pdc of 0.8 or greater 
G9514 Req ret or w/in 90d of surg Patient required a return to the operating room within 90 days of surgery 
G9515 No reas no ret or w/in 90d Patient did not require a return to the operating room within 90 days of surgery 
G9516 Impr vis acuit w/in 90d Patient achieved an improvement in visual acuity from their preoperative level within 90 days of surgery 
G9517 No impr vis acuit w/in 90d Patient did not achieve an improvement in visual acuity from their preoperative level within 90 days of surgery reason not given 
G9518 Doc active inj drug use Documentation of active injection drug use 
G9519 Final ref +/- 1.0 w/in 90d Patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery 
G9520 Refract not +/- 1.0 w/in 90d Patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery 
G9521 Er and ip hosp <2 in 12 mos Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months 
G9522 Er/ip hosp =/>2 in 12 mos Total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened reason not given 
G9523 D/c hemo or perit dialysis Patient discontinued from hemodialysis or peritoneal dialysis 
G9524 Refer to hospice Patient was referred to hospice care 
G9525 Doc pt reas no hospice refer Documentation of patient reason(s) for not referring to hospice care (e.g. patient declined other patient reasons) 
G9526 No reason no refer hospice Patient was not referred to hospice care reason not given 
G9529 Minor blunt trauma w/head ct Patient with minor blunt head trauma had an appropriate indication(s) for a head ct 
G9530 Pt mbht hd ct ord ec prov Patient presented with a minor blunt head trauma  and had a head ct ordered for trauma by an emergency care provider 
G9531 Pt doc Patient has documentation of ventricular shunt brain tumor multisystem trauma or is currently taking an antiplatelet medication including: abciximab anagrelide cangrelor cilostazol clopidogrel dipyridamole eptifibatide prasugrel ticlopidine ticagrelor tirofiban or vorapaxar 
G9532 Pt hd ct ord Patient had a head ct for trauma ordered by someone other than an emergency care provider  or was ordered for a reason other than trauma 
G9533 Indic for head ct not valid Patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct 
G9534 Adv brain image not ordered Advanced brain imaging (cta ct mra or mri) was not ordered 
G9535 Normal neuro exam Patients with a normal neurological examination 
G9536 Doc med reas adv brain image Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e. patient has an abnormal neurological examination; patient has the coexistence of seizures or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g. papilledema absent venous pulsations on funduscopic examination altered mental status focal neurologic deficits signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms) 
G9537 Doc sysm rsn img hd Documentation of system reason(s) for obtaining imaging of the head (ct or mri) (i.e. needed as part of a clinical trial; other clinician ordered the study) 
G9538 Adv brain image ordered Advanced brain imaging (cta ct mra or mri) was ordered 
G9539 Intent pot remv time placemt Intent for potential removal at time of placement 
G9540 Pt alive 3 mos post proc Patient alive 3 months post procedure 
G9541 Filter rem 3 mon plmt Filter removed within 3 months of placement 
G9542 Doc reass appr remo filt 3ms Documented re-assessment for the appropriateness of filter removal within 3 months of placement 
G9543 Doc 2x re-assess filt remov Documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement 
G9544 No filt remov w/in 3mos plcm Patients that do not have the filter removed documented re-assessment for the appropriateness of filter removal or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement 
G9547 Cys ren les or adren Cystic renal lesion that is simple appearing (bosniak i or ii)  or adrenal lesion  less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols 
G9548 No f/u rec image study Final reports for imaging studies stating no  follow-up imaging is recommended 
G9549 Doc med rsn for f/u imag Documentation of medical reason(s) that follow-up imaging is indicated (e.g. patient has lymphadenopathy signs of metastasis or an active diagnosis or history of cancer and other medical reason(s)) 
G9550 Imag rec Final reports for imaging studies with follow-up imaging recommended 
G9551 Imag no les Final reports for imaging studies without an incidentally found lesion noted 
G9552 Inc thyr node <1.0 in rpt Incidental thyroid nodule < 1.0 cm noted in report 
G9553 Prior thyroid dise dx Prior thyroid disease diagnosis 
G9554 Ct/cta/mri/a chst foll rec Final reports for ct cta mri or mra of the chest or neck or ultrasound of the neck with follow-up imaging recommended 
G9555 Doc med rsn for follup image Documentation of medical reason(s) for recommending follow up imaging (e.g. patient has multiple endocrine neoplasia patient has cervical lymphadenopathy other medical reason(s)) 
G9556 Ct/cta/mri/a no follup imag Final reports for ct cta mri or mra of the chest or neck or ultrasound of the neck with follow-up imaging not recommended 
G9557 Ct/cta/mri/a no thyr <1.0cm Final reports for ct cta mri or mra studies of the chest or neck or ultrasound of the neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found 
G9558 Tx beta-lactam abx therapy Patient treated with a beta-lactam antibiotic as definitive therapy 
G9559 Doc med reas no abx therapy Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g. allergy intolerance to beta-lactam antibiotics) 
G9560 No beta-lactam abx ther rng Patient not treated with a beta-lactam antibiotic as definitive therapy reason not given 
G9561 Presc opiates >6 wks Patients prescribed opiates for longer than six weeks 
G9562 Foll-up eval q3mo opiod tx Patients who had a follow-up evaluation conducted at least every three months during opioid therapy 
G9563 No f/u eval q3mo opiod tx Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy 
G9572 Phq-scr >9 doc in 12m time Index date phq-score greater than 9 documented during the twelve month denominator identification period 
G9573 Adl pt md or dys rem 6 mon Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five 
G9574 Adl pt md dys no rem 6 mon Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five 
G9577 Presc opiates >6 wks Patients prescribed opiates for longer than six weeks 
G9578 Doc opioid tx 1x during ther Documentation of signed opioid treatment agreement at least once during opioid therapy 
G9579 No doc opioid tx 1x at ther No documentation of signed an opioid treatment agreement at least once during opioid therapy 
G9580 Door to punc time <2hrs Door to puncture time of less than 2 hours 
G9581 Md doc door to punc tm >2hr Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g. patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment) 
G9582 Door to punc time >2hr nrg Door to puncture time of greater than 2 hours no reason given 
G9583 Presc opiates >6 wks Patients prescribed opiates for longer than six weeks 
G9584 Eval opioid use instr/pt int Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g. opioid risk tool soapp-r) or patient interviewed at least once during opioid therapy 
G9585 No eval opi use instr/intv Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g. opioid risk tool soapp-r) or patient not interviewed at least once during opioid therapy 
G9593 Low pecarn ped head trauma Pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules 
G9594 Pt mbht hd ct ord ec prov Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider 
G9595 Doc shnt/tum/coag Patient has documentation of ventricular shunt brain tumor or coagulopathy 
G9596 Ped pt hd ct ord Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma 
G9597 No low pecarn ped head traum Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules 
G9598 Aor ane 5.5-5.9 cm max diam Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct 
G9599 Aor ane >=6.0 cm max diam Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct 
G9600 Symp aaa urgent repair Symptomatic aaas that required urgent/emergent (non-elective) repair 
G9601 Pt dchg home post op day 7 Patient discharge to home no later than post-operative day #7 
G9602 Pt no dchg home postop day 7 Patient not discharged to home by post-operative day #7 
G9603 Pt surv improv bsline tx Patient survey score improved from baseline following treatment 
G9604 Pt surv results not avail Patient survey results not available 
G9605 Surv score no improv w/tx Patient survey score did not improve from baseline following treatment 
G9606 Intraop cyst eval trac inj Intraoperative cystoscopy performed to evaluate for lower tract injury 
G9607 Doc med rsn not perf cystosc Documented medical reasons for not performing intraoperative cystoscopy (e.g. urethral pathology precluding cystoscopy any patient who has a congenital or acquired absence of the urethra) or in the case of patient death 
G9608 Intraop cyst eval not done Intraoperative cystoscopy not performed to evaluate for lower tract injury 
G9609 Doc order anti-plat Documentation of an order for anti-platelet agents 
G9610 Doc md rsn no antipla Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents 
G9611 No doc order anti-plat rng Order for anti-platelet agents was not documented in the patient's record reason not given 
G9612 Phodoc 2 mr cec lndmk Photodocumentation of two or more cecal landmarks to establish a complete examination 
G9613 Doc post surg anatomy Documentation of post-surgical anatomy (e.g. right hemicolectomy ileocecal resection etc.) 
G9614 Photodoc < 2 cec lndmk Photodocumentation of less than two cecal landmarks (i.e. no cecal landmarks or only one cecal landmark) to establish a complete examination 
G9615 Pre-op asst doc Preoperative assessment documented 
G9616 Doc rsn no preop assmt Documentation of reason(s) for not documenting a preoperative assessment (e.g. patient with a gynecologic or other pelvic malignancy noted at the time of surgery) 
G9617 Pre-op asst not doc rng Preoperative assessment not documented reason not given 
G9618 Doc scr uter mal or us/samp Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind 
G9619 Doc rsn no scr uter malig Documentation of reason(s) for not screening for uterine malignancy (e.g. prior hysterectomy) 
G9620 No scr utr malig/us/samp rng Patient not screened for uterine malignancy or those that have not had an ultrasound and/or endometrial sampling of any kind reason not given 
G9621 Scr unheal etoh w/counsel Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling 
G9622 No unheal etoh user Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method 
G9623 Doc med rsn no scr etoh use Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g. limited life expectancy other medical reasons) 
G9624 Pt not scrn or no counseling Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user reason not given 
G9625 Pt bl srg 30 day pst srg Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery 
G9626 Med rsn no rpt baldder inj Documented medical reason for not reporting bladder injury (e.g. gynecologic or other pelvic malignancy documented concurrent surgery involving bladder pathology injury that occurs during urinary incontinence procedure patient death from non-medical causes not related to surgery patient died during procedure without evidence of bladder injury) 
G9627 Pt no bl srg 30 day pst srg Patient did not sustain bladder injury at the time of surgery nor discovered  subsequently up to 30n days post-surgery 
G9628 Pt bwli srg 30 day pst srg Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days  post-surgery 
G9629 Med rsn no rpt bowel inj Documented medical reasons for not reporting bowel injury (e.g. gynecologic or other pelvic malignancy documented planned (e.g. not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel or patient death from non-medical causes not related to surgery patient died during procedure without evidence of bowel injury) 
G9630 Pt no bwli srg 30 day srg Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery 
G9631 Pt ui srg 30 day pst srg Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery 
G9632 Med rsn for no rpt uret inj Documented medical reasons for not reporting ureter injury (e.g. gynecologic or other pelvic malignancy documented concurrent surgery involving bladder pathology injury that occurs during a urinary incontinence procedure patient death from non-medical causes not related to surgery patient died during procedure without evidence of ureter injury) 
G9633 Pt no ui srg 30 day pst srg Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery 
G9634 Qual life tool 2x same/impr Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved 
G9635 No doc rsn do qual life assm Health-related quality of life not assessed with tool for documented reason(s) (e.g. patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey patient has the inability to read and/or write in order to complete the hrqol questionnaire) 
G9636 No life asst 2x same/decr Health-related quality of life not assessed with tool during at least two visits or quality of life score declined 
G9637 Doc >1 dose reduc tech Final reports with documentation of one or more dose reduction techniques (e.g. automated exposure control adjustment of the ma and/or kv according to patient size use of iterative reconstruction technique) 
G9638 No doc >1 dose reduc tech Final reports without documentation of one or more dose reduction techniques (e.g. automated exposure control adjustment of the ma and/or kv according to patient size use of iterative reconstruction technique) 
G9639 Amp no reqd in48h ieler proc Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure 
G9640 Doc plan hybrid/stage proc Documentation of planned hybrid or staged procedure 
G9641 Amp reqd w/in 48h ieler proc Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure 
G9642 Current smoker Current smokers (e.g. cigarette cigar pipe e-cigarette or marijuana) 
G9643 Elective surgery Elective surgery 
G9644 No smok b/4 anes day of surg Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure 
G9645 Had smoke b/4 anes day surg Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure 
G9646 Pt w/90d mrs 0-2 Patients with 90 day mrs score of 0 to 2 
G9647 No mrs score in 90d followup Patients in whom mrs score could not be obtained at 90 day follow-up 
G9648 Pt w/90d mrs >2 Patients with 90 day mrs score greater than 2 
G9649 Psor as doc spc bm Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g. (pga; 5-point or 6-point scale) body surface area (bsa) psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) 
G9650 Doc pt no ther chg or contra Documentation that the patient declined therapy change or has documented contraindications (e.g. experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga bsa pasi or dlqi 
G9651 Psor as doc no spc bm Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g. (pga; 5-point or 6-point scale) body surface area (bsa) psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented 
G9652 Pt tx sys bio med psori 6mth Patient has been treated with a systemic or biologic medication for psoriasis for at least six months 
G9653 Pt no tx sys bio rx 6 mths Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months 
G9654 Mon anesth care Monitored anesthesia care (mac) 
G9655 Toc tool incl key elem A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used 
G9656 Pt trans from anest to pacu Patient transferred directly from anesthetizing location to pacu or other non-icu location 
G9657 Toc dur aneth to icu Transfer of care during an anesthetic or to the intensive care unit 
G9658 Toc tool incl elem not used A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used 
G9659 >85y no hx colo ca/rsn scope Patients greater than 85 years of age who did not have a history of colorectal cancer or valid medical reason for the colonoscopy including: iron deficiency anemia lower gastrointestinal bleeding crohn's disease (i.e. regional enteritis) familial adenomatous polyposis lynch syndrome (i.e. hereditary non-polyposis colorectal cancer) inflammatory bowel disease ulcerative colitis abnormal finding of gastrointestinal tract or changes in bowel habits 
G9660 Doc med rsn scope pt >85y Documentation of medical reason(s) for a colonoscopy performed on a patient greater than 85 years of age (e.g. last colonoscopy incomplete last colonoscopy had inadequate prep iron deficiency anemia lower gastrointestinal bleeding crohn's disease (i.e. regional enteritis) familial history of adenomatous polyposis lynch syndrome (i.e. hereditary non-polyposis colorectal cancer) inflammatory bowel disease ulcerative colitis abnormal finding of gastrointestinal tract or changes in bowel habits) 
G9661 >85y scope othr rsn Patients greater than 85 years of age who received a routine colonoscopy for a reason other than the following: an assessment of signs/symptoms of gi tract illness and/or the patient is considered high risk and/or to follow-up on previously diagnosed advance lesions 
G9662 Prior dx/active clin ascvd Previously diagnosed or have an active diagnosis of clinical ascvd 
G9663 Fast/dir ldl <= 190 mg/dl Any fasting or direct ldl-c laboratory test result <= 190 mg/dl 
G9664 Taking statin or rec'd order Patients who are currently statin therapy users or received an order (prescription) for statin therapy 
G9665 No statin/no order statin Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy 
G9666 Fas/dir ldl 70-189mg/dl mst The highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period 
G9667 Doc med rsn no stat tx/presc Documentation of medical reason(s) for not currently being a statin   therapy user or receive an order (prescription) for statin therapy (e.g. patient with adverse effect allergy or intolerance to statin medication therapy patients who have an active diagnosis of pregnancy or who are breastfeeding patients who are receiving palliative care patients with active liver disease or hepatic disease or insufficiency patients with end stage renal disease (esrd) and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy) 
G9669 Intend rpt mult chr msr grp I intend to report the multiple chronic conditions measures group 
G9670 Qty act mcc mg perf All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient 
G9671 Intend rpt dia retin msr grp I intend to report the diabetic retinopathy measures group 
G9672 Qty act diab retin mg perf All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient 
G9673 Intend rpt card prev msr grp I intend to report the cardiovascular prevention measures group 
G9674 Pt w/clin ascvd dx Patients with clinical ascvd diagnosis 
G9675 Pt w/fast/dir lab ldl-c >190 Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl 
G9676 40-75y w/type 1/2 w/ldl-c rs Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70?189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period 
G9677 Qty act card prev mg perf All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient 
G9678 Oncology care model service Oncology care model (ocm) monthly enhanced oncology services (meos) payment for  ocm enhanced services.  g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement 
G9679 Acute care pneumonia This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary 
G9680 Acute care congestive heart This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary 
G9681 Acute care chronic obstruct This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary 
G9682 Acute care skin infection This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary 
G9683 Acute fluid/electro disorder Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project 
G9684 Acute care urinary tract inf This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary 
G9685 Acute nursing facility care Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project 
G9686 Nursing facility conference Onsite nursing facility conference that is separate and distinct from an evaluation and management visit including qualified practitioner and at least one member of the nursing facility interdisciplinary care team 
G9687 Hospice anytime msmt per Hospice services provided to patient any time during the measurement period 
G9688 Pt w/hosp anytime msmt per Patients using hospice services any time during the measurement period 
G9689 Inpt elect carotid intervent Patient admitted for performance of elective carotid intervention 
G9690 Pt in hos Patient receiving hospice services any time during the measurement period 
G9691 Pt hosp dur msmt period Patient had hospice services any time during the measurement period 
G9692 Hosp recd by pt dur msmt per Hospice services received by patient any time during the measurement period 
G9693 Pt use hosp during msmt per Patient use of hospice services any time during the measurement period 
G9694 Hosp srv used pt in msmt per Hospice services utilized by patient any time during the measurement period 
G9695 Long act inhal bronchdil pre Long-acting inhaled bronchodilator prescribed 
G9696 Med rsn no presc bronchdil Documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator 
G9697 Pt rsn no presc bronchdil Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator 
G9698 Sys rsn no presc bronchdil Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator 
G9699 Long inhal bronchdil no pres Long-acting inhaled bronchodilator not prescribed reason not otherwise specified 
G9700 Pt is w/hosp during msmt per Patients who use hospice services any time during the measurement period 
G9701 Child anbx 30 prior dx estab Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established 
G9702 Pt use hosp during msmt per Patients who use hospice services any time during the measurement period 
G9703 Child anbx 30 prior dx phary Children who are taking antibiotics in the 30 days prior to the  diagnosis of pharyngitis 
G9704 Ajcc br ca stg i: t1 mic/t1a Ajcc breast cancer stage i: t1 mic or t1a documented 
G9705 Ajcc br ca stg ib Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented 
G9706 Low recur prost ca Low (or very low) risk of recurrence prostate cancer 
G9707 Pt had hosp dur msmt per Patient received hospice services any time during the measurement period 
G9708 Bilat mast/hx bi /unilat mas Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy 
G9709 Hosp srv used pt in msmt per Hospice services used by patient any time during the measurement period 
G9710 Pt prov hosp srv msmt per Patient was provided hospice services any time during the measurement period 
G9711 Pt hx tot col or colon ca Patients with a diagnosis or past history of total colectomy or colorectal cancer 
G9712 Doc med rsn presc anbx Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g. intestinal   infection pertussis bacterial infection lyme disease otitis media acute sinusitis acute pharyngitis acute tonsillitis chronic sinusitis infection of the pharynx/larynx/tonsils/adenoids prostatitis cellulitis/ mastoiditis/bone infections acute lymphadenitis impetigo skin staph infections pneumonia gonococcal infections/venereal disease (syphilis chlamydia inflammatory diseases [female reproductive organs]) infections of the kidney cystitis/uti acne hiv disease/asymptomatic hiv cystic fibrosis disorders of the immune system malignancy neoplasms chronic bronchitis emphysema bronchiectasis extrinsic allergic alveolitis chronic airway obstruction chronic obstructive asthma pneumoconiosis and other lung disease due to external agents other diseases of the respiratory system and tuberculosis 
G9713 Pt use hosp during msmt per Patients who use hospice services any time during the measurement period 
G9714 Pt is w/hosp during msmt per Patient is using hospice services any time during the measurement period 
G9715 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9716 Bmi doc onl fup not cmpltd Bmi is documented as being outside of normal limits follow-up plan is not completed for documented reason 
G9717 Doc pt dx dep/bp f/u nt req Documentation stating the patient has an active diagnosis of depression or has a diagnosed bipolar disorder therefore screening or follow-up not required 
G9718 Hospice anytime msmt per Hospice services for patient provided any time during the measurement period 
G9719 Pt not ambul/immob/wc Patient is not ambulatory bed ridden immobile confined to chair wheelchair bound dependent on helper pushing wheelchair independent in wheelchair or minimal help in wheelchair 
G9720 Hospice anytime msmt per Hospice services for patient occurred any time during the measurement period 
G9721 Pt not ambul/immob/wc Patient not ambulatory bed ridden immobile confined to chair wheelchair bound dependent on helper pushing wheelchair independent in wheelchair or minimal help in wheelchair 
G9722 Doc hx renal fail or cr+ >4 Documented history of renal failure or baseline serum creatinine = 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure unless since transplantation the cr has been or is 4.0 or higher 
G9723 Hosp recd by pt dur msmt per Hospice services for patient received any time during the measurement period 
G9724 Pt w/doc use anticoag mst yr Patients who had documentation of use of anticoagulant medications overlapping the measurement year 
G9725 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9726 Refused to participate Patient refused to participate 
G9727 Pt unable cmplt knee fs prom Patient unable to complete the knee fs prom at initial evaluation and/or discharge due to blindness illiteracy severe mental incapacity or language incompatibility and an adequate proxy is not available 
G9728 Refused to participate Patient refused to participate 
G9729 Pt unbl cmplt hip fs prom Patient unable to complete the hip fs prom at initial evaluation and discharge due to blindness illiteracy severe mental incapacity or language incompatibility and an adequate proxy is not available 
G9730 Refused to participate Patient refused to participate 
G9731 Pt unbl cmplt ft/ank fs prom Patient unable to complete the ankle/foot fs prom at initial evaluation and/or discharge due to blindness illiteracy severe mental incapacity or language incompatibility and an adequate proxy is not available 
G9732 Refused to participate Patient refused to participate 
G9733 Pt unbl cmplt lb fs prom Patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness illiteracy severe mental incapacity or language incompatibility and an adequate proxy is not available 
G9734 Refused to participate Patient refused to participate 
G9735 Pt unbl cmplt shld fs prom Patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness illiteracy severe mental incapacity or language incompatibility and an adequate proxy is not available 
G9736 Refused to participate Patient refused to participate 
G9737 Pt unbl cmplt ewh fs prom Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness illiteracy severe mental incapacity or language incompatibility and an adequate proxy is not available 
G9738 Refused to participate Patient refused to participate 
G9739 Pt unbl cmplt go fs prom Patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness illiteracy severe mental incapacity or language incompatibility and an adequate proxy is not available 
G9740 Hosp srv to pt dur msmt per Hospice services given to patient any time during the measurement period 
G9741 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9742 Psych sympt assessed Psychiatric symptoms assessed 
G9743 Psych symp not assessed rns Psychiatric symptoms not assessed reason not otherwise specified 
G9744 Pt not eli d/t act dig htn Patient not eligible due to active diagnosis of hypertension 
G9745 Doc rsn no hbp scrn or f/u Documented reason for not screening or recommending a follow-up for high blood pressure 
G9746 Mit sten valve or trans af Patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g. pneumonia hyperthyroidism pregnancy cardiac surgery) 
G9747 Pall dialysis with catheter Patient is undergoing palliative dialysis with a catheter 
G9748 App transpl lvg kidney donor Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant 
G9749 Pall dialysis with catheter Patient is undergoing palliative dialysis with a catheter 
G9750 App transpl lvg kidney donor Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant 
G9751 Pt died w/in 24 mos rpt time Patient died at any time during the 24-month measurement period 
G9752 Urgent surgery Emergency surgery 
G9753 Doc no dicom ct other fac Documentation of medical reason for not conducting a search for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure authorized media-free shared archive (e.g. trauma acute myocardial infarction stroke aortic aneurysm where time is of the essence) 
G9754 Incid pulm nodule A finding of an incidental pulmonary nodule 
G9755 Doc med rsn no fllw up Documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up and source of recommendations (e.g. patients with unexplained fever immunocompromised patients who are at risk for infection) 
G9756 Surg proc w/silicone oil Surgical procedures that included the use of silicone oil 
G9757 Surg proc w/silicone oil Surgical procedures that included the use of silicone oil 
G9758 Pt in hos Patient in hospice at any time during the measurement period 
G9759 Hx preop post cap rup History of preoperative posterior capsule rupture 
G9760 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9761 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9762 Pt had >= 2-3 hpv vaccines Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays 
G9763 Pt not have 2-3 hpv vaccines Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays 
G9764 Pt treatd w/oral syst or bio Patient has been treated with a systemic medication for psoriasis vulgaris 
G9765 Doc pat declined therapy Documentation that the patient declined change in medication or alternative therapies were unavailable has documented contraindications or has not been treated with a systemic medication for at least six consecutive months (e.g. experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga bsa pasi or dlqi 
G9766 Cva stroke dx tx transf fac Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment 
G9767 Hosp new dx cva consid evst Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment 
G9768 Pt w/hosp anytime msmt per Patients who utilize hospice services any time during the measurement period 
G9769 Bn den 2yr/got ost med/ther Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months 
G9770 Perip nerve block Peripheral nerve block (pnb) 
G9771 Anes end 1 temp >35.5(95.9) At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time 
G9772 Doc med rsn no temp >= 35.5 Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time (e.g. emergency cases intentional hypothermia etc.) 
G9773 1 bod temp >=35.5 At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time reason not given 
G9774 Pt had hyst Patients who have had a hysterectomy 
G9775 Recd 2 anti-emet pre/intraop Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively 
G9776 Doc med rsn no proph antiem Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively  (e.g. intolerance or other medical reason) 
G9777 Pt no antiemet pre/intraop Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively 
G9778 Pts dx w/pregn Patients who have a diagnosis of pregnancy 
G9779 Pts breastfeeding Patients who are breastfeeding 
G9780 Pts dx w/rhabdomyolysis Patients who have a diagnosis of rhabdomyolysis 
G9781 Doc rsn no statin Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g. patient with adverse effect allergy or intolerance to statin medication therapy patients who are receiving palliative or hospice care patients with active liver disease or hepatic disease or insufficiency and patients with end stage renal disease (esrd)) 
G9782 Hx dx fam/pure hypercholes History of or active diagnosis of familial or pure hypercholesterolemia 
G9783 Doc dx dm fast <70 no stat Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy 
G9784 Path/derm prov 2nd biop opin Pathologists/dermatopathologists providing a second opinion on a biopsy 
G9785 Path report sent Pathology report diagnosing cutaneous basal cell carcinoma squamous cell carcinoma or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist 
G9786 Path report not sent Pathology report diagnosing cutaneous basal cell carcinoma squamous cell carcinoma or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist 
G9787 Pt alive Patient alive as of the last day of the measurement year 
G9788 Most rct bp </= 140/90 Most recent bp is less than or equal to 140/90 mm hg 
G9789 Record bp ip er urg/self Blood pressure recorded during inpatient stays emergency room visits urgent care visits and patient self-reported bp's (home and health fair bp results) 
G9790 Most rct bp >/= 140/90 Most recent bp is greater than 140/90 mm hg or blood pressure not documented 
G9791 Most rct tob stat free Most recent tobacco status is tobacco free 
G9792 Most rct tob stat not free Most recent tobacco status is not tobacco free 
G9793 Pt on daily asa/antiplat Patient is currently on a daily aspirin or other antiplatelet 
G9794 Doc med rsn no daily aspirin Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed intra-cranial bleed idiopathic thrombocytopenic purpura (itp) gastric bypass or documentation of active anticoagulant use during the measurement period) 
G9795 Pt no daily asa/antiplat Patient is not currently on a daily aspirin or other antiplatelet 
G9796 Pt not currently on statin Patient is currently on a statin therapy 
G9797 Pt currently on statin Patient is not on a statin therapy 
G9798 D/c ami btw 7/1-6/30 meas pd Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period 
G9799 Med disp evt indic hx asth Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period 
G9800 Pt id intol/alleg beta-block Patients who are identified as having an intolerance or allergy to beta-blocker therapy 
G9801 Nonacut transf from inpt Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis 
G9802 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9803 Pt presc 135 day trmt Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami 
G9804 Pt not presc 135 day trmt Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami 
G9805 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9806 Pt recd cerv cyto/hpv Patients who received cervical cytology or an hpv test 
G9807 Pt no recd cerv cyto/hpv Patients who did not receive cervical cytology or an hpv test 
G9808 Pt no asthm cont med mst per Any patients who had no asthma controller medications dispensed during the measurement year 
G9809 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9810 Pdc 75% w/asth cont med Patient achieved a pdc of at least 75% for their asthma controller medication 
G9811 No pdc 75% w/asth cont med Patient did not achieve a pdc of at least 75% for their asthma controller medication 
G9812 Pt died during inpt/30d aft Patient died including all deaths occurring during the hospitalization in which the operation was performed even if after 30 days and those deaths occurring after discharge from the hospital but within 30 days of the procedure 
G9813 Pt not died w/in 30d of proc Patient did not die within 30 days of the procedure or during the index hospitalization 
G9814 Death during index hosp Death occurring during the index acute care hospitalization 
G9815 Death not during index hosp Death did not occur during the index acute care hospitalization 
G9816 Death <30 day post discharge Death occurring after discharge from the hospital but within 30 days post procedure 
G9817 No death 30-days post-disch Death did not occur after discharge from the hospital within 30 days post procedure 
G9818 Doc sex activity Documentation of sexual activity 
G9819 Pt w/hosp anytime msmt per Patients who use hospice services any time during the measurement period 
G9820 Doc chlam scr test w/follow Documentation of a chlamydia screening test with proper follow-up 
G9821 No doc chlam scr ts w/follow No documentation of a chlamydia screening test with proper follow-up 
G9822 Endo abl proc yr prev ind dt Women who had an endometrial ablation procedure during the year prior to the index date (exclusive of the index date) 
G9823 Endo smpl/hyst bx res doc Endometrial sampling or hysteroscopy with biopsy and results documented 
G9824 Endo smpl/hyst bx res no doc Endometrial sampling or hysteroscopy with biopsy and results not documented 
G9825 Her-2 negundoc/unkn Her-2/neu negative or undocumented/unknown 
G9826 Transf pract aft init chemo Patient transferred to practice after initiation of chemotherapy 
G9827 Her-2 targ ther no init tx Her2-targeted therapies not administered during the initial course of treatment 
G9828 Her-2 targ ther dur init tx Her2-targeted therapies administered during the initial course of treatment 
G9829 Breast adj chemo admin Breast adjuvant chemotherapy administered 
G9830 Her-2 pos Her-2/neu positive 
G9831 Ajcc stg brt ca dx ii or iii Ajcc stage at breast cancer diagnosis = ii or iii 
G9832 Brt ca dx i no t1/t1a/t1b Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1 t1a t1b 
G9833 Transf pract aft init chemo Patient transfer to practice after initiation of chemotherapy 
G9834 Pt met dis at dx Patient has metastatic disease at diagnosis 
G9835 Trastuz given w/in 12 mos dx Trastuzumab administered within 12 months of diagnosis 
G9836 Rsn no trast given doc Reason for not administering trastuzumab documented (e.g. patient declined patient died patient transferred contraindication or other clinical exclusion neoadjuvant chemotherapy or radiation not complete) 
G9837 Trastuz not in 12 mos dx Trastuzumab not administered within 12 months of diagnosis 
G9838 Pt met dis at dx Patient has metastatic disease at diagnosis 
G9839 Anti-egfr mon anti ther Anti-egfr monoclonal antibody therapy 
G9840 Gene testing performed Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab 
G9841 Gene testing not performed Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab 
G9842 Pt met dis at dx Patient has metastatic disease at diagnosis 
G9843 Kras or nras gene mutation Ras (kras or nras) gene mutation 
G9844 Pt no recd anti-egfr ther Patient did not receive anti-egfr monoclonal antibody therapy 
G9845 Pt recd anti-egfr ther Patient received anti-egfr monoclonal antibody therapy 
G9846 Pt died from cancer Patients who died from cancer 
G9847 Pt recd chemo last 14d life Patient received chemotherapy in the last 14 days of life 
G9848 Pt no chemo last 14d life Patient did not receive chemotherapy in the last 14 days of life 
G9849 Pt died from cancer Patients who died from cancer 
G9850 1/more ed last 30d life Patient had more than one emergency department visit in the last 30 days of life 
G9851 1/no ed visit last 30d life Patient had one or less emergency department visits in the last 30 days of life 
G9852 Pt died from cancer Patients who died from cancer 
G9853 Icu stay last 30d life Patient admitted to the icu in the last 30 days of life 
G9854 No icu stay last 30d life Patient was not admitted to the icu in the last 30 days of life 
G9855 Pt died from cancer Patients who died from cancer 
G9856 Pt no hospice Patient was not admitted to hospice 
G9857 Pt admit hospice Patient admitted to hospice 
G9858 Pt enroll hospice Patient enrolled in hospice 
G9859 Pt died from cancer Patients who died from cancer 
G9860 Pt less 3d hospice Patient spent less than three days in hospice care 
G9861 Pt more than 3d hospice Patient spent greater than or equal to three days in hospice care 
G9862 Doc rsn no 10 yr follow Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g. inadequate prep familial or personal history of colonic polyps patient had no adenoma and age is = 66 years old or life expectancy < 10 years old other medical reasons) 
G9868 Next gen aco model <10min Receipt and analysis of remote asynchronous images for dermatologic and/or ophthalmologic evaluation for use under the next generation aco model less than 10 minutes 
G9869 Next gen aco model 10-20min Receipt and analysis of remote asynchronous images for dermatologic and/or ophthalmologic evaluation for use under the next generation aco model 10-20 minutes 
G9870 Next gen aco model >20min Receipt and analysis of remote asynchronous images for dermatologic and/or ophthalmologic evaluation for use under the next generation aco model 20 or more minutes 
G9873 1 em core session First medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions 
G9874 4 em core sessions Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions 
G9875 9 em core sessions Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions 
G9876 2 em core ms mo 7-9 no wl Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at a core maintenance session in months 7-9 
G9877 2 em core ms mo 10-12 no wl Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at a core maintenance session in months 10-12 
G9878 2 em core ms mo 7-9 wl Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at a core maintenance session in months 7-9 
G9879 2 em core ms mo 10-12 wl Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at a core maintenance session in months 10-12 
G9880 Em 5 percent wl The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session 
G9881 Em 9 percent wl The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session core maintenance session or ongoing maintenance session 
G9882 2 em ongoing ms mo 13-15 wl Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15 
G9883 2 em ongoing ms mo 16-18 wl Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18 
G9884 2 em ongoing ms mo 19-21 wl Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21 
G9885 2 em ongoing ms mo 22-24 wl Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24 
G9890 Em bridge payment Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session core maintenance session or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model.  a supplier may only receive one bridge payment per mdpp beneficiary 
G9891 Em session reporting Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em)  hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only) 
G9892 Doc pt rsn no dil mac exam Documentation of patient reason(s) for not performing a dilated macular examination 
G9893 No mac exam Dilated macular exam was not performed reason not otherwise specified 
G9894 Adr dep thrpy prescribed Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate 
G9895 Doc med rsn no adr dep thrpy Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g. salvage therapy) 
G9896 Doc pt rsn no adr dep thrpy Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate 
G9897 Pt nt prsc adr dep thrpy rng Patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate reason not given 
G9898 Pt 66+ snp or ltc pos Patient age 65 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G9899 Scrn mam perf rslts doc Screening diagnostic film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed 
G9900 Scrn mam perf rslts not doc Screening diagnostic film digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed reason not otherwise specified 
G9901 Pt 66+ snp or ltc pos Patient age 65 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G9902 Pt scrn tbco and id as user Patient screened for tobacco use and identified as a tobacco user 
G9903 Pt scrn tbco id as non user Patient screened for tobacco use and identified as a tobacco non-user 
G9904 Doc med rsn no tbco scrn Documentation of medical reason(s) for not screening for tobacco use (e.g. limited life expectancy other medical reason) 
G9905 No pt tbco scrn rng Patient not screened for tobacco use reason not given 
G9906 Pt recv tbco cess interv Patient identified as a tobacco user received tobacco cessation intervention (counseling and/or pharmacotherapy) 
G9907 Doc med rsn no tbco interv Documentation of medical reason(s) for not providing tobacco cessation intervention (e.g. limited life expectancy other medical reason) 
G9908 No pt tbco cess interv rng Patient identified as tobacco user did not receive tobacco cessation intervention (counseling and/or pharmacotherapy) reason not given 
G9909 Doc med rsn no tbco interv Documentation of medical reason(s) for not  providing tobacco cessation intervention if identified as a tobacco user (eg limited life expectancy other medical reason) 
G9910 Pt 66+ snp or ltc pos Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G9911 Node neg pre/post syst ther Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant  systemic therapy 
G9912 Hbv status assesed and int Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy 
G9913 No hbv status assesd and int Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy reason not given 
G9914 Pt receiving anti-tnf agent Patient receiving an anti-tnf agent 
G9915 No documntd hbv results rcd No record of hbv results documented 
G9916 Funct status past 12 months Functional status  performed once in the last 12 months 
G9917 Adv dem crgvr limited Documentation of advanced stage dementia and caregiver knowledge is limited 
G9918 No funct stat perf rsn nos Functional status not performed reason not otherwise specified 
G9919 Scrn nd pos nd prov of rec Screening performed and positive and provision of recommendations 
G9920 Scrning perf and negative Screening performed and negative 
G9921 No or part scrn nd rng or os No screening performed partial screening performed or positive screen without recommendations and reason is not given or otherwise specified 
G9922 Sfty cncrns scrn nd mit recs Safety concerns screen provided and if positive then documented mitigation recommendations 
G9923 Safty cncrns scrn and neg Safety concerns screen provided and negative 
G9924 Doc med rsn no scrn or recs Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations orders or referrals for positive screen (e.g. patient in palliative care other medical reason) 
G9925 No scrn prov rsn nos Safety concerns screening not provided reason not otherwise specified 
G9926 Sfty cncrns scrn but no recs Safety concerns screening positive screen is without provision of mitigation recommendations including but not limited to referral to other resources 
G9927 Doc no warf /fda  pt trial Documentation of system reason(s) for not prescribing warfarin or another fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment 
G9928 No warf or fda drug presc Warfarin or another fda-approved anticoagulant not prescribed reason not given 
G9929 Trs/rev af Patient with transient or reversible cause of af (e.g. pneumonia hyperthyroidism pregnancy cardiac surgery) 
G9930 Com care Patients who are receiving comfort care only 
G9931 No chad or chad scr 0 or 1 Documentation of cha2ds2-vasc risk score of 0 or 1 
G9932 Doc pt rsn no tb scrn recrds Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g. patient does not return for mantoux (ppd) skin test evaluation) 
G9933 Canc detectd during col scrn Adenoma(s) or colorectal cancer detected during screening colonoscopy 
G9934 Doc rsn not detecting cancer Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma sessile serrated polyp or sessile serrated adenoma 
G9935 Canc not detectd during srcn Adenoma(s) or colorectal cancer not detected during screening colonoscopy 
G9936 Pmh plyp/neo co/rect/jun/ans Surveillance colonoscopy - personal history of colonic polyps colon cancer or other malignant neoplasm of rectum rectosigmoid junction and anus 
G9937 Dig or surv colsco Diagnostic colonoscopy 
G9938 Pt 66+ snp or ltc pos Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32 33 34 54 or 56 for more than 90 days during the measurement period 
G9939 Same path/derm perf biopsy Pathologists/dermatopathologists is the same clinician who performed the biopsy 
G9940 Doc reas no statin therapy Documentation of medical reason(s) for not on a statin (e.g. pregnancy in vitro fertilization clomiphene rx esrd cirrhosis muscular pain and disease during the measurement period or prior year) 
G9941 Pre and post vas wthn 3 mos Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively 
G9942 Adtl spine proc on same date Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy 
G9943 Bk pn nt msr vas scl pre/pst Back pain was not measured by the visual analog scale (vas) within three months preoperatively and at three months ( 6 - 20 weeks)  postoperatively 
G9944 Vas 3 mon pre and 1 yr post Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year  (9 to 15 months) postoperatively 
G9945 Pt w/cancer  scoliosis Patient had cancer fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis 
G9946 Bk pain no vas Back pain was not measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively 
G9947 Pre and post vas wthn 3 mos Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively 
G9948 Adtl spine proc on same date Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy 
G9949 Leg pain no vas Leg pain was not measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively 
G9954 Pt >2 rsk fac post-op vomit Patient exhibits 2 or more risk factors for post-operative vomiting 
G9955 Inhlnt anesth only for induc Cases in which an inhalational anesthetic is used only for induction 
G9956 Combo thrpy of >= 2 prophly Patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively 
G9957 Doc med rsn no combo thrpy Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g. intolerance or other medical reason) 
G9958 No combo prohpyl thrp for pt Patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively 
G9959 Systemic antimicro not presc Systemic antimicrobials not prescribed 
G9960 Med rsn sys antimi nt rx Documentation of medical reason(s) for prescribing systemic antimicrobials 
G9961 Systemic antimicro presc Systemic antimicrobials prescribed 
G9962 Embolization doc separatly Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy 
G9963 Embolization not doc separat Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy 
G9964 Pt recv >=1 well-chld visit Patient received at least one well-child visit with a pcp during the performance period 
G9965 No well-chld vist recv by pt Patient did not receive at least one well-child visit with a pcp during the performance period 
G9966 Scrn inter report child Children who were screened for risk of developmental behavioral and social delays using a standardized tool with interpretation and report 
G9967 No scrn inter reprt child Children who were not screened for risk of developmental behavioral and social delays using a standardized tool with interpretation and report 
G9968 Pt refrd 2 pvdr/spclst in pp Patient was referred to another provider or specialist during the performance period 
G9969 Pvdr rfrd pt rprt rcvd Provider who referred the patient to another provider received a report from the provider to whom the patient was referred 
G9970 Pvdr rfrd pt no rprt rcvd Provider who referred the patient to another provider did not receive a report from the provider to whom the patient was referred 
G9974 Mac exam perf Dilated macular exam performed including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity 
G9975 Doc med rsn no dil mac exam Documentation of medical reason(s) for not performing a dilated macular examination 
G9978 Remote e/m new pt 10mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are self limited or minor. typically 10 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9979 Remote e/m new pt 20mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires these 3 key components: an expanded problem focused history;  an expanded problem focused examination; straightforward medical decision making furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are of low to moderate severity. typically 20 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9980 Remote e/m new pt 30 mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting  problem(s) are of moderate severity. typically 30 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9981 Remote e/m new pt 45mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are of moderate to high severity. typically 45 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9982 Remote e/m new pt 60mins Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are of moderate to high severity. typically 60 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9983 Remote e/m est. pt 10mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are self limited or minor. typically 10 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9984 Remote e/m est. pt  15mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are of low to moderate severity. typically 15 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9985 Remote e/m est. pt 25mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires at least 2 of the following 3 key components: a detailed history;  a detailed examination; medical decision making of moderate complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are of moderate to high severity. typically 25 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9986 Remote e/m est. pt 40mins Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually the presenting problem(s) are of moderate to high severity. typically 40 minutes are spent with the patient or family or both via real time audio and video intercommunications technology 
G9987 Bpci advanced in home visit Bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound including but not necessarily limited to patient assessment of clinical status safety/fall prevention functional status/ambulation medication reconciliation/management compliance with orders/plan of care performance of activities of daily living and ensuring beneficiary  connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code 
